{ "company": "Thermo Fisher Scientific", "ticker": "TMO", "period": { "from": "2026-03-19", "to": "2026-04-18", "days": 30 }, "sentiment_breakdown": { "positive": 94, "negative": 36, "neutral": 70 }, "synthesis": { "executive_summary": "Sentiment analysis for Thermo Fisher Scientific (TMO) from 2026-03-19 to 2026-04-18. Analyzed 200 items across FDA and news sources.", "key_findings": [], "overall_sentiment": "neutral" }, "top_positive": [ { "title": "Immunohistochemistry Market Led by Diagnostics Segment with 60%+ Share; Market Projected to Reach USD 4.42 billion by 2031, Mordor Intelligence Reports", "date": "2026-04-10", "source": "news", "score": 1.0 }, { "title": "Active Pharmaceutical Ingredients CDMO Market Research and Global Forecast Report 2025-2032: Exploring Service Models, Analytical Services, Process Developments, and More", "date": "2026-04-09", "source": "news", "score": 1.0 }, { "title": "Biopharmaceuticals Contract Manufacturing Market Global Forecast Report 2026-2032: A Cornerstone for Operational Efficiency, Agility, and Strategic Focus Amid a Rapidly Evolving Therapeutic Landscape", "date": "2026-04-08", "source": "news", "score": 1.0 }, { "title": "Pharmaceutical Excipient Market - Global Forecast 2026-2032: Growth Driven by Innovation, Compliance Needs, and Digital Procurement with Emphasis on Supply Resilience, and Sustainability,", "date": "2026-04-08", "source": "news", "score": 1.0 }, { "title": "Cell Line Development Market to Reach $8.95 Bn by 2031 with Gene & Cell Therapy Manufacturing Growing at 10.88% CAGR, Says Mordor Intelligence", "date": "2026-04-14", "source": "news", "score": 0.958 }, { "title": "Global Metabolomics Market Poised for Strong Growth as Advancements in Precision Medicine and Biomarker Discovery Accelerate Adoption: Verified Market Research®", "date": "2026-04-10", "source": "news", "score": 0.951 }, { "title": "$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics", "date": "2026-04-09", "source": "news", "score": 0.943 }, { "title": "Pharma B2B ECommerce Global Market Forecast 2026-2032 - Opportunities Lie in Digital Integration, Resilient Supply Chains, Real-time Transparency, and Compliance", "date": "2026-04-09", "source": "news", "score": 0.904 }, { "title": "Nanotechnology Market to Grow at 13.21% CAGR to Reach USD 220.8 Billion by 2031, Supported by Healthcare Expansion and Clean Energy Initiatives, Reports Mordor Intelligence", "date": "2026-04-15", "source": "news", "score": 0.883 }, { "title": "Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032", "date": "2026-04-09", "source": "news", "score": 0.883 } ], "top_negative": [ { "title": "Donald Trump’s Racism Mirrors Jeffrey Epstein’s", "date": "2026-04-16", "source": "news", "score": -0.938 }, { "title": "Template-driven scaffolding of SCFFBXO42 regulates PP2A degradation", "date": "2026-04-15", "source": "news", "score": -0.869 }, { "title": "Companion Diagnostics Market Size is Projected to Hit USD 26.38 Billion by 2035 – SNS Insider", "date": "2026-04-13", "source": "news", "score": -0.869 }, { "title": "Three Fatal Gestational Psittacosis Cases Caused by Chlamydia psittaci Strains Belonging to Closely Related Lineages, Japan", "date": "2026-04-16", "source": "news", "score": -0.848 }, { "title": "Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology", "date": "2026-04-09", "source": "news", "score": -0.823 }, { "title": "Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.", "date": "2026 Apr 9", "source": "pubmed", "score": -0.718 }, { "title": "Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.", "date": "2026 Mar 2", "source": "pubmed", "score": -0.67 }, { "title": "NSUN4-mediated m5C RNA methylation protects retinal cells against excitotoxic injury via the SHH signaling pathway", "date": "2026-04-15", "source": "news", "score": -0.621 }, { "title": "OpenAI launches GPT-Rosalind, a specialised AI model for drug discovery and life sciences research", "date": "2026-04-17", "source": "news", "score": -0.582 }, { "title": "Messenger Ribo Nucleic Acid (mRNA) Vaccine Contract Development and Manufacturing Organization (CDMO) Market Research and Global Forecast Report 2026-2035", "date": "2026-04-14", "source": "news", "score": -0.542 } ], "raw_data": { "total_items": 200, "items": [ { "source": "sec", "filing_type": "8-K", "title": "8-K - Current report", "date": "2026-03-24", "url": "https://www.sec.gov/Archives/edgar/data/97745/000009774526000066/0000097745-26-000066-index.htm", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific launches Applied Biosystems™ PowerFlex™ Thermal Cycler", "url": "https://www.biospectrumindia.com/news/16/27680/thermo-fisher-scientific-launches-applied-biosystems-powerflex-thermal-cycler.html", "date": "2026-04-18", "summary": "Thermo Fisher Scientific has unveiled the Applied Biosystems PowerFlex Thermal Cycler, a new PCR instrument designed to enhance flexibility, thermal performance, and productivity in molecular biology labs. This next-generation system aims to help laboratories manage complex PCR workflows with greater confidence and efficiency. It features advanced thermal technology to shorten run times while maintaining accuracy and is suitable for various applications, including life science research, academic", "sentiment_score": 0.438461, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Proteomics Collaboration Advances Population Health Study", "url": "https://www.technologynetworks.com/proteomics/product-news/proteomics-collaboration-advances-population-health-study-411795", "date": "2026-04-18", "summary": "Thermo Fisher Scientific has announced a collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, a large-scale biobank initiative. This partnership aims to leverage proteomics and AI-driven analytics to gain insights into disease biology for earlier detection and personalized care. The initiative will integrate Thermo Fisher's Olink® Proximity Extension Assay and Orbitrap Astral mass spectrometry systems with Seer’s Proteograph® Product Suite to cre", "sentiment_score": 0.40947, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "OpenAI Launches GPT-Rosalind AI Model Tailored for Drug Discovery and Biology Research", "url": "https://mlq.ai/news/openai-launches-gpt-rosalind-ai-model-tailored-for-drug-discovery-and-biology-research/", "date": "2026-04-17", "summary": "OpenAI has introduced GPT-Rosalind, a specialized AI model developed for early-stage drug discovery and life sciences research, covering areas like biochemistry, genomics, and protein engineering. This model integrates with over 50 scientific databases and is initially accessible through a vetted US enterprise program with partners including Amgen, Moderna, and Thermo Fisher Scientific. GPT-Rosalind has demonstrated superior performance on various scientific benchmarks, surpassing human experts ", "sentiment_score": 0.306294, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.939173, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "From genome to therapy: How HiFi long-read sequencing is helping to accelerate next-generation cancer drug research and development", "url": "https://www.pacb.com/blog/from-genome-to-therapy-how-hifi-long-read-sequencing-is-helping-to-accelerate-next-generation-cancer-drug-research-and-development/", "date": "2026-04-17", "summary": "HiFi long-read sequencing offers a comprehensive approach to cancer drug development by providing detailed genomic, transcriptomic, and epigenetic insights. This technology enables better detection of complex structural variants, improves neoantigen discovery for immunotherapies, and characterizes epigenetic dysregulation. By integrating these multiomic data, HiFi sequencing can accelerate target identification, biomarker validation, and the development of precision medicines and advanced cell t", "sentiment_score": 0.299383, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.734797, "sentiment": { "label": "negative", "score": -0.494, "confidence": 0.49 } }, { "source": "alpha_vantage", "title": "VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability", "url": "https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/vasro-ainos-expands-smell-ai-from-industrials-into-healthcare-inf-1158458", "date": "2026-04-17", "summary": "Ainos, Inc. is expanding its Smell AI technology, powered by AI Nose, into healthcare infrastructure, adding to its existing deployments in semiconductor and robotics industries. This move, highlighted by a VASRO GmbH report, establishes 2026 as a critical scale-up year for Ainos as it transitions from ecosystem development to real-world deployment and repeatable revenue generation. The company is collaborating with MacKay Memorial Hospital and Topco Scientific Co., Ltd. for initial applications", "sentiment_score": 0.304003, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.628745, "sentiment": { "label": "positive", "score": 0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators", "url": "https://www.marketsmojo.com/news/stocks-in-action/thermo-fisher-scientifics-technical-trend-shifts-from-mildly-bullish-to-bearish-amid-stock-decline-3945829", "date": "2026-04-17", "summary": "Thermo Fisher Scientific recently saw a stock price decline and a technical trend adjustment, with its current price at $500.46. Performance indicators are mixed, showing bearish signals on weekly MACD and moving averages, but the company has significantly outperformed the S&P 500 over the past decade with a 251.92% return. Stakeholders are advised to closely monitor market dynamics due to these fluctuating indicators.", "sentiment_score": -0.211087, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity", "url": "https://www.biospace.com/press-releases/thermo-fisher-scientific-launches-applied-biosystems-powerflex-thermal-cycler-to-advance-pcr-flexibility-and-productivity", "date": "2026-04-17", "summary": "Thermo Fisher Scientific has introduced the Applied Biosystems™ PowerFlex™ Thermal Cycler, a new PCR instrument designed to enhance flexibility, thermal performance, and productivity for molecular biology laboratories. This next-generation system aims to meet the demands of complex PCR workflows with features like precise thermal control, an intuitive touchscreen interface, and flexible configurations including a 3x32-well model for simultaneous experiments. The PowerFlex Thermal Cycler is inten", "sentiment_score": 0.469475, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Cystoscopy and Ureteroscopy Market 2026 | Stryker Corp, Rudra Surgicals, Teleflex Inc, Coloplast Corp etc.", "url": "https://www.openpr.com/news/4476095/cystoscopy-and-ureteroscopy-market-2026-stryker-corp-rudra", "date": "2026-04-17", "summary": "The global Cystoscopy and Ureteroscopy Market is projected to reach US$ 729.30 million by 2031, driven by rising urological disorders, technological advancements, and increasing adoption of minimally invasive procedures. Key opportunities include healthcare infrastructure expansion in emerging markets and integration of AI in endoscopic imaging. Despite challenges like high device costs, the market is poised for sustained growth with a focus on affordable innovations and improved accessibility.", "sentiment_score": 0.305962, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.635793, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Bioprocessing: the hidden engine accelerating advances in our health", "url": "https://www.danaher.com/bioprocessing-hidden-engine-accelerating-advances-our-health", "date": "2026-04-16", "summary": "Bioprocessing, though not widely understood, is crucial for producing life-changing biologic medicines like monoclonal antibodies, gene therapies, and cell therapies. While scientific discovery is accelerating, manufacturing capabilities struggle to keep pace due to the complexity and sensitivity of biologic production, creating constraints in patient access and affordability. Overcoming these challenges requires continuous innovation in process technologies, digital systems, resilient supply ch", "sentiment_score": 0.339965, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.635095, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher stock may benefit following collaboration with PRECISE", "url": "https://www.msn.com/en-us/health/other/thermo-fisher-stock-may-benefit-following-collaboration-with-precise/ar-AA20BmFP", "date": "2026-04-16", "summary": "This article suggests that Thermo Fisher Scientific's stock could see a positive impact due to its collaboration with PRECISE. The nature and details of this collaboration would likely be the driving factor behind any potential stock benefit. Investors may want to monitor developments from this partnership.", "sentiment_score": 0.543145, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.459, "confidence": 0.46 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows", "url": "https://biopharmaapac.com/news/120/7834/thermo-fisher-introduces-powerflex-thermal-cycler-to-simplify-complex-pcr-workflows.html", "date": "2026-04-16", "summary": "Thermo Fisher Scientific has announced the Applied Biosystems PowerFlex Thermal Cycler, a new PCR instrument designed to enhance flexibility, precision, and productivity in molecular biology labs. This next-generation system aims to simplify complex PCR workflows, offering features like fast thermal performance, an intuitive interface, and flexible configurations including a 3x32-well option for simultaneous experiments. It addresses the growing demand for adaptable and user-friendly thermal cyc", "sentiment_score": 0.625889, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows", "url": "https://biopharmaapac.com/news/29/7834/thermo-fisher-introduces-powerflex-thermal-cycler-to-simplify-complex-pcr-workflows.html", "date": "2026-04-16", "summary": "Thermo Fisher Scientific has launched the Applied Biosystems PowerFlex Thermal Cycler, a new PCR instrument designed to enhance flexibility, precision, and productivity in molecular biology labs. This next-generation system aims to simplify complex PCR workflows, offering fast thermal performance, intuitive operation via a 10.1-inch touchscreen, and flexible configurations including 96-well and 3x32-well models. It is intended for a broad range of applications in life science research, biotechno", "sentiment_score": 0.433219, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity", "url": "https://www.morningstar.com/news/business-wire/20260416083174/thermo-fisher-scientific-launches-applied-biosystems-powerflex-thermal-cycler-to-advance-pcr-flexibility-and-productivity", "date": "2026-04-16", "summary": "Thermo Fisher Scientific has unveiled the Applied Biosystems™ PowerFlex™ Thermal Cycler, a new PCR instrument designed to enhance flexibility, thermal performance, and productivity for molecular biology labs. This next-generation system aims to help laboratories manage complex PCR workflows with greater confidence and efficiency, offering features like fast, precise thermal performance, an intuitive interface, and flexible configurations including a 3x32-well model for simultaneous independent e", "sentiment_score": 0.455106, "sentiment_label": "Bullish", "relevance_score": 0.960016, "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity", "url": "https://finance.yahoo.com/sectors/healthcare/articles/thermo-fisher-scientific-launches-applied-123000650.html", "date": "2026-04-16", "summary": "Thermo Fisher Scientific has launched the Applied Biosystems™ PowerFlex™ Thermal Cycler, a new PCR instrument designed to enhance flexibility, thermal performance, and productivity in molecular biology laboratories. This next-generation system aims to address the challenges of complex PCR workflows with fast and precise results, intuitive operation via a 10.1-inch touchscreen, and flexible configurations including a 3x32-well model for simultaneous independent experiments. The PowerFlex Thermal ", "sentiment_score": 0.428607, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity", "url": "https://www.businesswire.com/news/home/20260416083174/en/Thermo-Fisher-Scientific-Launches-Applied-Biosystems-PowerFlex-Thermal-Cycler-to-Advance-PCR-Flexibility-and-Productivity", "date": "2026-04-16", "summary": "Thermo Fisher Scientific has launched the Applied Biosystems™ PowerFlex™ Thermal Cycler, a new PCR instrument designed to enhance flexibility, thermal performance, and productivity in molecular biology labs. This next-generation system aims to address the growing demand for accurate and fast PCR results, especially in labs with complex workflows and shared instruments. Key features include fast and precise thermal performance, intuitive operation via a touchscreen, and flexible configurations, i", "sentiment_score": 0.452616, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. $TMO Shares Purchased by KBC Group NV", "url": "https://www.marketbeat.com/instant-alerts/filing-thermo-fisher-scientific-inc-tmo-shares-purchased-by-kbc-group-nv-2026-04-16/", "date": "2026-04-16", "summary": "KBC Group NV increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.2% in the fourth quarter, purchasing 11,953 additional shares to own a total of 243,329 shares valued at approximately $141 million. This highlights significant institutional ownership in the company, with other major firms like Wellington Management, BNY Mellon, Franklin Resources, and Capital World Investors also boosting their positions. Analysts currently rate TMO as a \"Moderate Buy\" with an average price targe", "sentiment_score": 0.404574, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Lbp Am Sa Sells 56,190 Shares of Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-lbp-am-sa-sells-56190-shares-of-thermo-fisher-scientific-inc-tmo-2026-04-16/", "date": "2026-04-16", "summary": "Lbp Am Sa reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 20.8% in the fourth quarter, selling 56,190 shares and now holding 214,300 shares valued at approximately $124.2 million. This positions TMO as its 13th-largest holding. The medical research company reported strong Q4 results, beating EPS estimates with $6.57 and increasing revenue by 7.2% year-over-year, while also raising its quarterly dividend to $0.47.", "sentiment_score": 0.291407, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Transient Protein Expression Market Key Players | Thermo Fisher Scientific, Promega Corporation, Merck KGAA, Qiagen", "url": "https://www.openpr.com/news/4474318/transient-protein-expression-market-key-players-thermo-fisher", "date": "2026-04-16", "summary": "The Transient Protein Expression Market is projected to reach US$ 1,320.38 million by 2031, growing at a CAGR of 5.9% from US$ 836.68 million in 2023. This growth is driven by increasing demand for rapid protein production in drug discovery and vaccine development, with technological advancements and a rising focus on personalized medicine contributing to its expansion. Key market players include Thermo Fisher Scientific, Promega Corporation, Merck KGAA, and Qiagen, contributing to continuous in", "sentiment_score": 0.33779, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Genotyping Market Major Players - QIAGEN NV, Merck KGaA, Eurofins Genomics, BioTek Instruments Inc", "url": "https://www.openpr.com/news/4474377/genotyping-market-major-players-qiagen-nv-merck-kgaa", "date": "2026-04-16", "summary": "The global Genotyping Market is projected to reach US$ 154.35 billion by 2031 from US$ 30.44 billion in 2023, growing at a CAGR of 22.5%. This growth is driven by the rapid adoption of precision medicine, expanding research in biotechnology, and declining costs of genotyping technologies. Key trends include the integration of AI, use in agriculture, and advancements in gene-editing technologies, with North America leading the market.", "sentiment_score": 0.637819, "sentiment_label": "Bullish", "relevance_score": 0.699731, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Border to Coast Pensions Partnership Ltd Acquires 30,245 Shares of Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-border-to-coast-pensions-partnership-ltd-acquires-30245-shares-of-thermo-fisher-scientific-inc-tmo-2026-04-16/", "date": "2026-04-16", "summary": "Border to Coast Pensions Partnership Ltd increased its stake in Thermo Fisher Scientific Inc. by 17.8% during the fourth quarter, acquiring an additional 30,245 shares. This brought their total holdings to 200,442 shares, valued at approximately $116.36 million, making Thermo Fisher their 9th largest holding. The company also recently reported strong Q4 results, beating analyst expectations for EPS and revenue, and increased its quarterly dividend.", "sentiment_score": 0.311632, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.496, "confidence": 0.5 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. $TMO Shares Sold by Consolidated Investment Group LLC", "url": "https://www.marketbeat.com/instant-alerts/filing-thermo-fisher-scientific-inc-tmo-shares-sold-by-consolidated-investment-group-llc-2026-04-16/", "date": "2026-04-16", "summary": "Consolidated Investment Group LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 21.8% in Q4 2025, selling 3,000 shares and retaining a significant holding valued at $6.22 million. Despite this reduction, institutional ownership remains high, with other major firms increasing their positions. Analysts maintain a \"Moderate Buy\" rating for TMO with a consensus target price of $631.25, following the company's strong Q4 earnings, dividend increase, and recent insider sales.", "sentiment_score": 0.221171, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Assetmark Inc. Raises Position in Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-assetmark-inc-raises-position-in-thermo-fisher-scientific-inc-tmo-2026-04-16/", "date": "2026-04-16", "summary": "Assetmark Inc. significantly increased its stake in Thermo Fisher Scientific ($TMO) by 22.9% in Q4, holding 37,654 shares valued at $21.82 million. Institutional investors now own nearly 90% of the stock, while analysts maintain a \"Moderate Buy\" consensus with an average target price of $631.25. Thermo Fisher also surpassed quarterly earnings expectations and raised its quarterly dividend.", "sentiment_score": 0.539405, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific (TMO) to Release Quarterly Earnings on Thursday", "url": "https://www.marketbeat.com/instant-alerts/thermo-fisher-scientific-tmo-to-release-quarterly-earnings-on-thursday-2026-04-16/", "date": "2026-04-16", "summary": "Thermo Fisher Scientific (TMO) is set to release its Q1 2026 earnings before market open on Thursday, April 23rd, with analysts expecting $5.25 EPS and $10.8606 billion in revenue. The company recently increased its quarterly dividend to $0.47 per share and has a consensus \"Moderate Buy\" rating from analysts with an average price target of $631.25. Recent insider transactions include CEO Marc N. Casper selling 5,000 shares for over $2.5 million.", "sentiment_score": 0.286157, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Annex Advisory Services LLC Acquires 3,469 Shares of Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-annex-advisory-services-llc-acquires-3469-shares-of-thermo-fisher-scientific-inc-tmo-2026-04-15/", "date": "2026-04-16", "summary": "Annex Advisory Services LLC increased its stake in Thermo Fisher Scientific Inc. by 19.7% with the acquisition of 3,469 shares, bringing its total holdings to 21,089 shares valued at $12.22 million. Several other major institutions also increased their positions in TMO, contributing to an overall institutional ownership of 89.23%. Analysts currently rate TMO as a \"Moderate Buy\" with an average price target of $631.25, while company insiders have recently sold some shares.", "sentiment_score": 0.447863, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "How Investors May Respond To Qiagen (QGEN) Entering Rapid Bloodstream Infection Testing With New Panel", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-qgen/qiagen/news/how-investors-may-respond-to-qiagen-qgen-entering-rapid-bloo", "date": "2026-04-16", "summary": "QIAGEN N.V. (QGEN) has expanded its QIAstat-Dx platform into rapid bloodstream infection testing with a new CE-IVDR-certified panel, QIAstat-Dx BCID GPF Plus AMR. This move is expected to strengthen Qiagen's syndromic testing menu and align with hospital needs for rapid sepsis management and antimicrobial stewardship. While this expansion is a positive catalyst for QIAstat-Dx adoption, investors should also consider the increasing competition in the syndromic testing market.", "sentiment_score": 0.14828, "sentiment_label": "Neutral", "relevance_score": 0.640591, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Agilent Technologies Inc stock (US00846U1016): Why its life sciences leadership matters more now for investors", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/agilent-technologies-inc-stock-us00846u1016-why-its-life-sciences/69167210", "date": "2026-04-15", "summary": "Agilent Technologies Inc. (US00846U1016) is highlighted as a resilient investment in the life sciences sector, providing essential analytical tools and services for drug discovery, clinical testing, and environmental monitoring. The article details its three key revenue segments—Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab—emphasizing the high-margin, recurring revenue from its services arm. Agilent's strong financial health, consistent free cash flow, and ex", "sentiment_score": 0.100448, "sentiment_label": "Neutral", "relevance_score": 0.692784, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Animal Health Market Intelligence Report 2026-2034 Featuring Strategic Analysis of Bayer, Elanco, Merck, Merial, Zoetis, Boehringer Ingelheim, Ceva Sante Animale, Heska and More", "url": "https://finance.yahoo.com/sectors/healthcare/articles/animal-health-market-intelligence-report-151600373.html", "date": "2026-04-15", "summary": "The global animal health market is projected to grow from USD 40.1 billion in 2025 to USD 51.6 billion by 2034, driven by factors like increasing awareness of zoonotic diseases, technological advancements, and pet humanization. North America currently leads the market, while Asia Pacific and Europe show rapid growth. Key players include Bayer, Elanco, Merck, and Zoetis, focusing on innovations in veterinary drugs, diagnostics, and telemedicine.", "sentiment_score": 0.242316, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.63075, "sentiment": { "label": "positive", "score": 0.477, "confidence": 0.48 } }, { "source": "alpha_vantage", "title": "Danaher Corp. stock (US2358511028): Why does its business model matter more now for long-term invest", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-corp-stock-us2358511028-why-does-its-business-model-matter/69158449", "date": "2026-04-15", "summary": "Danaher Corp. (US2358511028) is highlighted for its resilient business model driven by science-driven innovation and disciplined capital allocation in life sciences and diagnostics. The company's decentralized structure and Danaher Business System (DBS) ensure continuous improvement and consistent margin expansion, making it an attractive long-term investment for those seeking stability and growth in essential healthcare trends. Analysts view Danaher favorably due to its strong economic moat, re", "sentiment_score": 0.341224, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.61736, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Waters Corp stock (US94106L1098): Why its leadership in analytical instruments matters more now for", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/waters-corp-stock-us94106l1098-why-its-leadership-in-analytical/69157969", "date": "2026-04-15", "summary": "Waters Corp (WAT) is a leading provider of high-performance liquid chromatography and mass spectrometry tools, critical for pharmaceuticals, biotech, and materials science. The company's focus on innovation, diversified end-markets, and strong financial stability positions it as an evergreen investment in the life sciences sector. Its emphasis on digital solutions, sustainability, and recurring revenue from consumables further solidifies its market relevance for investors seeking defensive growt", "sentiment_score": 0.102463, "sentiment_label": "Neutral", "relevance_score": 0.649226, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Illumina Inc. stock (US4523271090): Why does its genomics dominance matter more now for U.S. investo", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/illumina-inc-stock-us4523271090-why-does-its-genomics-dominance-matter/69154713", "date": "2026-04-15", "summary": "Illumina Inc. (US4523271090) maintains a leading position in genomic sequencing, which is crucial for precision medicine, particularly in the U.S. and English-speaking markets. The company's \"razor-and-blade\" business model, supported by high-margin consumables and advanced sequencing platforms like NovaSeq, provides a stable revenue stream. While facing competition and regulatory challenges, Illumina's continuous innovation, strategic acquisitions, and integration into global healthcare initiat", "sentiment_score": 0.227799, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.622797, "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "alpha_vantage", "title": "Qiagen N.V. stock (NL0012169213): Why does its sample-to-insight business model matter more for U.S.", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/qiagen-n-v-stock-nl0012169213-why-does-its-sample-to-insight-business/69154718", "date": "2026-04-15", "summary": "Qiagen N.V.'s \"sample-to-insight\" business model is increasingly relevant for US investors due to its focus on automated solutions for molecular diagnostics and research, directly supporting precision medicine. This model provides exposure to stable demand from labs and pharma, emphasizing scalable automation and recurring revenue from consumables. Analysts view this approach favorably for its resilience, competitive moat, and alignment with high-growth areas like genomics and infectious disease", "sentiment_score": -0.144846, "sentiment_label": "Neutral", "relevance_score": 0.647184, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Is Thermo Fisher (TMO) Quietly Rewiring Its AI Strategy Through New Data and Proteomics Alliances?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/is-thermo-fisher-tmo-quietly-rewiring-its-ai-strategy-throug", "date": "2026-04-15", "summary": "Thermo Fisher Scientific (TMO) has recently announced several collaborations, including a data partnership with HealthVerity and a proteomics alliance with Precision Health Research Singapore. These moves are seen as deepening Thermo Fisher's role in clinical development, precision health, and biomanufacturing by integrating its offerings with large datasets and clinical workflows. The HealthVerity partnership, in particular, strengthens Thermo Fisher's AI-enabled clinical development narrative ", "sentiment_score": 0.321717, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Haemonetics Corp stock (US4041191090): Why its steady focus on blood management innovation matters m", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/haemonetics-corp-stock-us4041191090-why-its-steady-focus-on-blood/69149862", "date": "2026-04-14", "summary": "Haemonetics Corp (HAE) is a medical device company specializing in blood management solutions, including plasma and blood collection devices. Its appeal lies in its niche market leadership in automated plasma collection, supported by a \"razor-and-blade\" business model with recurring revenue from consumables. The company demonstrates strong financial health, operational discipline, and a commitment to shareholder returns, making it a stable investment in the healthcare sector, despite competition", "sentiment_score": 0.204776, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.637128, "sentiment": { "label": "positive", "score": 0.602, "confidence": 0.6 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific and PRECISE Partner on Singapore Proteomics Study", "url": "https://clpmag.com/lab-management/company-news/thermo-fisher-precise-singapore-proteomics-collaboration/", "date": "2026-04-14", "summary": "Thermo Fisher Scientific has partnered with Precision Health Research, Singapore (PRECISE) on the PRECISE-SG100K study, a population-scale biobank initiative. This collaboration aims to leverage multi-omic platforms and AI-driven analytics, particularly proteomics, to identify disease patterns, improve patient stratification, and advance personalized healthcare. The study will utilize Thermo Fisher's Olink and Orbitrap Astral systems, alongside Seer Proteograph Product Suite, generating insights", "sentiment_score": 0.452296, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Amazon to Acquire Globalstar in Cash-or-Stock Deal Offering $90 Per Share; Apple Agreements Updated", "url": "https://www.tradingview.com/news/tradingview:27709a47fb5fc:0-amazon-to-acquire-globalstar-in-cash-or-stock-deal-offering-90-per-share-apple-agreements-updated/", "date": "2026-04-14", "summary": "Globalstar has entered into a definitive merger agreement to be acquired by Amazon in a cash-or-stock deal valued at $90.00 per share, subject to certain adjustments. Concurrently, Globalstar and Apple have increased their maximum prepayment balance and amended their Statement of Work to align with program execution and the pending acquisition. Thermo, Globalstar's majority stockholder, has provided written consent, ensuring immediate stockholder approval of the merger.", "sentiment_score": 0.107877, "sentiment_label": "Neutral", "relevance_score": 0.638864, "sentiment": { "label": "positive", "score": 0.612, "confidence": 0.61 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market", "url": "https://www.marketwatch.com/data-news/thermo-fisher-scientific-inc-stock-rises-tuesday-outperforms-market-1fd88280-2abd5aea0f78?mod=mw_quote_news", "date": "2026-04-14", "summary": "Shares of Thermo Fisher Scientific Inc. (TMO) rose 2.53% to $527.22 on Tuesday, outperforming the broader market. This marked the stock's second consecutive day of gains, while the S&P 500 Index and Dow Jones Industrial Average also saw increases.", "sentiment_score": 0.434705, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Pharmacopoeia Requirements for Density Measurements", "url": "https://www.azom.com/article.aspx?ArticleID=25073", "date": "2026-04-14", "summary": "This article examines the diverse pharmacopoeial standards governing pharmaceutical density measurements globally, ensuring accuracy, consistency, and patient safety. It outlines the key international and regional requirements, including approved methods and measurement conditions laboratories must adhere to for compliance in quality control. The standards covered include the European Pharmacopoeia, International Pharmacopoeia, Chinese Pharmacopoeia, and United States Pharmacopoeia.", "sentiment_score": 0.142524, "sentiment_label": "Neutral", "relevance_score": 0.609678, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "How Investors Are Reacting To Illumina (ILMN) Board Turnover And Expanded Labcorp Precision Oncology Partnership", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ilmn/illumina/news/how-investors-are-reacting-to-illumina-ilmn-board-turnover-a", "date": "2026-04-14", "summary": "Illumina announced the retirement of three long-serving directors and expanded its precision oncology collaboration with Labcorp, tying its sequencing platforms more closely to clinical testing. This partnership, focusing on FDA-authorized products, is expected to be a key driver for Illumina's clinical growth and potentially reshape its earnings outlook, even as it prepares to report first-quarter 2026 results. The article examines how these developments are influencing investor perception and ", "sentiment_score": 0.046229, "sentiment_label": "Neutral", "relevance_score": 0.62297, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Qiagen N.V. stock (NL0012169213): Is sample-to-insight leadership strong enough to unlock new upside", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/qiagen-n-v-stock-nl0012169213-is-sample-to-insight-leadership-strong/69144198", "date": "2026-04-14", "summary": "This report analyzes Qiagen N.V.'s business model, its relevance in the U.S. and English-speaking markets, and the risks involved for investors. Qiagen focuses on sample-to-insight solutions in molecular diagnostics and life sciences, generating recurring revenue from high-margin consumables like reagents and kits. The company's growth is fueled by global demand for molecular diagnostics, advancements in gene and cell therapy, and its strong competitive position in sample prep technologies, thou", "sentiment_score": 0.118349, "sentiment_label": "Neutral", "relevance_score": 0.608344, "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "alpha_vantage", "title": "Qiagen N.V. stock (NL0012169213): Why does its molecular diagnostics edge matter more now for U.S. investors?", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/qiagen-n-v-stock-nl0012169213-why-does-its-molecular-diagnostics-edge/69143141", "date": "2026-04-14", "summary": "The article discusses why Qiagen N.V.'s molecular diagnostics capabilities are increasingly relevant for U.S. investors, highlighting the company's \"sample-to-insight\" business model and its comprehensive portfolio of tools. It covers key products, industry drivers, competitive strengths, and analyst views, while also addressing potential risks such as supply chain vulnerabilities and regulatory hurdles. Qiagen's focus on precise genomic testing and personalized medicine positions it as a key pl", "sentiment_score": 0.136325, "sentiment_label": "Neutral", "relevance_score": 0.632587, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities", "url": "https://www.biospace.com/press-releases/thermo-fisher-scientifics-ppd-clinical-research-business-collaborates-with-healthverity-to-expand-real-world-data-capabilities", "date": "2026-04-14", "summary": "Thermo Fisher Scientific's PPD clinical research business has announced a strategic collaboration with HealthVerity to enhance data-driven clinical development and evidence generation for biopharma sponsors. This agreement grants PPD enterprise-level access to HealthVerity's extensive TaXOnomy® claims dataset, covering over 270 million de-identified patient lives in the U.S. The partnership aims to provide deeper insights into disease patterns, treatment, and provider activity, strengthening PPD", "sentiment_score": 0.463781, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. $TMO Shares Acquired by Baillie Gifford & Co.", "url": "https://www.marketbeat.com/instant-alerts/filing-thermo-fisher-scientific-inc-tmo-shares-acquired-by-baillie-gifford-co-2026-04-13/", "date": "2026-04-14", "summary": "Baillie Gifford & Co. significantly increased its stake in Thermo Fisher Scientific, acquiring an additional 279,635 shares in Q4, bringing its total to 770,868 shares valued at approximately $446.7 million. This comes after Thermo Fisher Scientific exceeded Q4 earnings estimates, reporting an EPS of $6.57 and a revenue of $12.22 billion, and also announced an increased quarterly dividend of $0.47 per share. Analysts project an EPS of $23.28 for the current year, and the company maintains a \"Mod", "sentiment_score": 0.408367, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "TMO Technical Analysis | Trend, Signals & Chart Patterns | THERMO FISHER SCIENTIFIC INC (NYSE:TMO)", "url": "https://www.chartmill.com/stock/quote/TMO/technical-analysis", "date": "2026-04-14", "summary": "This article provides a technical analysis of Thermo Fisher Scientific Inc. (NYSE: TMO), rating it 3 out of 10. While TMO has been an average performer in the market and its industry, it shows neutral trends in both short and long term. The analysis details support and resistance levels, technical indicator signals like RSI and MACD, and notes some volatility and an overbought stochastic value.", "sentiment_score": 0.065989, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Assessing Charles River Laboratories (CRL) Valuation After Recent Share Price Rebound", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/assessing-charles-river-laboratories-crl-valuation-after-rec-2", "date": "2026-04-14", "summary": "Charles River Laboratories (CRL) has seen recent share price gains, up 15% over the past month, but is down 11.9% year-to-date. While Simply Wall St's narrative suggests CRL is 43.1% undervalued with a fair value of $313.61, their DCF model indicates it is overvalued at its current price of $178.34, with an estimated fair value of $134.83. The article highlights CRL's recent acquisition of a Cambodian primate supplier to secure NHP access, revealing a bottleneck in drug development, but also poi", "sentiment_score": 0.008327, "sentiment_label": "Neutral", "relevance_score": 0.638994, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc (TMO) Shares Surge 3.6% -- What GF Score of 88 Tells Investors", "url": "https://www.gurufocus.com/news/8790548/thermo-fisher-scientific-inc-tmo-shares-surge-36-what-gf-score-of-88-tells-investors", "date": "2026-04-13", "summary": "Thermo Fisher Scientific Inc (TMO) shares rose 3.6% today, with a current price of $514.23, indicating an 11.1% undervaluation compared to its GF Value™ of $578.18. The company boasts a strong GF Score™ of 88/100, though recent insider selling of $8.2 million without corresponding purchases suggests a need for investor caution. Despite the undervaluation and strong overall performance metrics like profitability and growth, the insider activity could signal potential challenges in the near term.", "sentiment_score": 0.303518, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific (TMO) Valuation Check As New PRECISE Collaboration Targets Long Term Precision Medicine Growth", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-scientific-tmo-valuation-check-as-new-precise", "date": "2026-04-13", "summary": "Thermo Fisher Scientific (TMO) recently announced a collaboration with Precision Health Research, Singapore for the PRECISE-SG100K biobank, aiming to advance precision medicine. Despite a mixed stock performance with a recent gain but year-to-date decline, analysts value the stock at a higher target price than its current trading price. The article discusses two valuation narratives: one suggesting it's undervalued based on long-term demand, and another flagging caution due to its P/E ratio.", "sentiment_score": 0.349648, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "alpha_vantage", "title": "Chromatograph (Labor): Precision Tools Drive Agilent's Lab Market Edge Amid Tech Boom", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/chromatograph-labor-precision-tools-drive-agilent-s-lab-market-edge/69139531", "date": "2026-04-13", "summary": "Agilent Technologies' chromatographs are critical precision tools for laboratory analysis in pharmaceuticals, environmental testing, and biotech, supporting high-stakes research. The company's strategic focus on innovation, sustainability, and recurring revenue from consumables positions it as a key player in the growing analytical instruments market. Despite challenges such as supply chain disruptions and competition, Agilent maintains a strong market position, driven by increasing lab automati", "sentiment_score": 0.133626, "sentiment_label": "Neutral", "relevance_score": 0.604386, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. stock rises Monday, outperforms market", "url": "https://www.marketwatch.com/data-news/thermo-fisher-scientific-inc-stock-rises-monday-outperforms-market-81bc1723-717ee9b9fc1f", "date": "2026-04-13", "summary": "Thermo Fisher Scientific Inc. (TMO) shares rose 3.65% to $514.23 on Monday, outperforming the broader market. The S&P 500 Index increased by 1.02% and the Dow Jones Industrial Average rose by 0.63% on the same day. This rise ended a two-day losing streak for the stock.", "sentiment_score": 0.547007, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Avantor Inc stock (US05352A1007): Why supply chain resilience matters more now for investors", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/avantor-inc-stock-us05352a1007-why-supply-chain-resilience-matters-more/69138978", "date": "2026-04-13", "summary": "This article examines why supply chain resilience is crucial for Avantor Inc, a global leader in life sciences services, in today's volatile market. It details the company's diversified operations, efforts to mitigate risks, and growth drivers like bioprocessing and sustainability, all while assessing its valuation and potential challenges. For investors, understanding Avantor's strategies for navigating supply chain pressures is key to evaluating its potential for steady returns and future grow", "sentiment_score": 0.139845, "sentiment_label": "Neutral", "relevance_score": 0.602484, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities", "url": "https://www.pharmiweb.com/press-release/2026-04-13/thermo-fisher-scientific-s-ppd-clinical-research-business-collaborates-with-healthverity-to-expand-r", "date": "2026-04-13", "summary": "Thermo Fisher Scientific's PPD clinical research business has announced a strategic collaboration with HealthVerity to significantly expand its real-world data (RWD) capabilities. This agreement provides enterprise-level access to HealthVerity’s TaXOnomy claims dataset, covering over 270 million de-identified U.S. patient lives, and a marketplace of additional curated data sources. The collaboration aims to enhance data-driven clinical development, optimize trial feasibility and recruitment, and", "sentiment_score": 0.018534, "sentiment_label": "Neutral", "relevance_score": 0.307329, "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "RNA Extraction and RNA Purification Research Report 2025: Market Industry Trends and Global Forecasts to 2035 - Approximately 175 Extraction Instruments Have Been Developed Across 70 Players", "description": "Key market opportunities in the RNA extraction and purification sector include the growing demand for RNA-based therapies and diagnostics, the development of user-friendly and automated kits, and the expanding academic and research activities. North America r…", "url": "https://www.globenewswire.com/news-release/2026/04/17/3275985/28124/en/RNA-Extraction-and-RNA-Purification-Research-Report-2025-Market-Industry-Trends-and-Global-Forecasts-to-2035-Approximately-175-Extraction-Instruments-Have-Been-Developed-Across-70-.html", "date": "2026-04-17", "published_at": "2026-04-17T09:03:00Z", "sentiment": { "label": "positive", "score": 0.421, "confidence": 0.42 } }, { "source": "news", "source_name": "The Next Web", "title": "OpenAI launches GPT-Rosalind, a specialised AI model for drug discovery and life sciences research", "description": "Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted…", "url": "https://thenextweb.com/news/openai-gpt-rosalind-life-sciences-drug-discovery-ai-model/", "date": "2026-04-17", "published_at": "2026-04-17T07:51:49Z", "sentiment": { "label": "negative", "score": -0.582, "confidence": 0.58 } }, { "source": "news", "source_name": "Torrentfreak.com", "title": "Korean Rights Holders Behind Takedown of Manga Piracy Giant TuMangaOnline", "description": "The Spanish-speaking manga community was in disarray last month when TuMangaOnline, also known as ZonaTMO, suddenly disappeared. When the site's main domain was put on clienthold by its registrar, it was clear that legal pressure was mounting. Today, Korean c…", "url": "https://torrentfreak.com/korean-rights-holders-behind-takedown-of-manga-piracy-giant-tumangaonline/", "date": "2026-04-17", "published_at": "2026-04-17T07:33:25Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "pymnts.com", "title": "OpenAI Targets Pharma Giants With Purpose-Built AI Model", "description": "OpenAI has introduced an artificial intelligence model that is purpose-built for scientific research and drug discovery. The new GPT-Rosalind features improved tool use and a deeper understanding of chemistry, protein engineering and genomics, the company sai…", "url": "https://www.pymnts.com/artificial-intelligence-2/2026/openai-targets-pharma-giants-with-purpose-built-ai-model/", "date": "2026-04-17", "published_at": "2026-04-17T02:18:28Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "Nature.com", "title": "A cell-permeable nanobody to restore F508del cystic fibrosis transmembrane conductance regulator activity", "description": "Cell-permeable nanobodies overcome a major barrier to intracellular protein targeting. Franz, Rubil and colleagues show that delivery of a CFTR-binding nanobody into airway epithelial cells from patients with cystic fibrosis homozygous for the F508del-CFTR mu…", "url": "https://www.nature.com/articles/s41589-026-02199-w", "date": "2026-04-17", "published_at": "2026-04-17T00:00:00Z", "sentiment": { "label": "positive", "score": 0.104, "confidence": 0.1 } }, { "source": "news", "source_name": "Openai.com", "title": "GPT‑Rosalind for life sciences research", "description": "OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.", "url": "https://openai.com/index/introducing-gpt-rosalind/", "date": "2026-04-16", "published_at": "2026-04-16T19:24:50Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "The Times of India", "title": "OpenAI launches AI model GPT-Rosalind for life sciences research", "description": "The GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support ‌research ⁠across biochemistry, drug ⁠discovery and translational medicine.", "url": "https://economictimes.indiatimes.com/tech/artificial-intelligence/openai-launches-ai-model-gpt-rosalind-for-life-sciences-research/articleshow/130317009.cms", "date": "2026-04-16", "published_at": "2026-04-16T19:14:03Z", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "Cdc.gov", "title": "Clusters of Invasive Haemophilus influenzae Type b Disease Among Adults Using Substances or Experiencing Homelessness or Housing Instability - Alaska, Oregon, and Washington, 2023─2025", "description": "This report describes two clusters of invasive of Haemophilus influenzae type b among adults with special risk factors in Alaska, Oregon, and Washington.", "url": "https://www.cdc.gov/mmwr/volumes/75/wr/mm7514a1.htm", "date": "2026-04-16", "published_at": "2026-04-16T17:00:00Z", "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "Pypi.org", "title": "teradatamodelops 7.2.7", "description": "Python client for Teradata ModelOps (TMO)", "url": "https://pypi.org/project/teradatamodelops/7.2.7/", "date": "2026-04-16", "published_at": "2026-04-16T15:45:09Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022–2023, 2023–2024, and 2024–2025 seasons", "description": "Seasonal influenza vaccines are available in multiple formulations including egg-based inactivated standard-dose, cell-based inactivated, recombinant, and live-attenuated. However, vaccine effectiveness and antibody responses vary by vaccine type, recipient a…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347314", "date": "2026-04-16", "published_at": "2026-04-16T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Genomic diversity analysis enables development of pan-Dengue Toehold RNA sensors", "description": "Author summary RNA viruses show high rates of sequence mutations, helping them evolve rapidly to evade the host immune system. This confounds diagnosis through detection tests where specific fragments from the viral genome are detected through designer sensor…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014173", "date": "2026-04-16", "published_at": "2026-04-16T14:00:00Z", "sentiment": { "label": "positive", "score": 0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "Plos.org", "title": "PDGFRα-positive mesenchymal stem/stromal cells contribute to autonomous vascular formation through in-body tissue architecture", "description": "Driven by endogenous platelet-derived growth factor receptor α (PDGFRα)-positive cells, in-body tissue architecture (iBTA) enables the autonomous formation of vascularized tissues within subcutaneously implanted molds, overcoming the limitations of traditiona…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347197", "date": "2026-04-16", "published_at": "2026-04-16T14:00:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "Fair Observer", "title": "Donald Trump’s Racism Mirrors Jeffrey Epstein’s", "description": "Jeffrey Epstein was not only a rapist and a child predator, but also — wait for it — a white supremacist. While some speculate that the Epstein issue is just a distraction from US President Donald Trump’s virulent and endless racism, others feel that the vide…", "url": "https://www.fairobserver.com/politics/donald-trumps-racism-mirrors-jeffrey-epsteins/", "date": "2026-04-16", "published_at": "2026-04-16T13:20:24Z", "sentiment": { "label": "negative", "score": -0.938, "confidence": 0.94 } }, { "source": "news", "source_name": "BBC News", "title": "Dragons rest trio in revamped side for Bulls game", "description": "Dragons rest Wales number eight Aaron Wainwright and co-captains Angus O'Brien and Ben Carter for the URC home match against Bulls on Friday.", "url": "https://www.bbc.com/sport/rugby-union/articles/cvgkky9707eo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-16", "published_at": "2026-04-16T11:00:35Z", "sentiment": { "label": "positive", "score": 0.077, "confidence": 0.08 } }, { "source": "news", "source_name": "Cdc.gov", "title": "Three Fatal Gestational Psittacosis Cases Caused by Chlamydia psittaci Strains Belonging to Closely Related Lineages, Japan", "description": "Fatal Gestational Psittacosis Cases, Japan", "url": "https://wwwnc.cdc.gov/eid/article/32/5/25-2008_article", "date": "2026-04-16", "published_at": "2026-04-16T04:00:00Z", "sentiment": { "label": "negative", "score": -0.848, "confidence": 0.85 } }, { "source": "news", "source_name": "Nature.com", "title": "Condensate corona–nanoparticle complexes transfer functional biomolecules between cells", "description": "After being internalized by cells, nanoparticles can, in rare events, acquire a biomolecular condensate corona. These complexes can reach the extracellular space, where they can deliver their acquired proteins and RNA content to other cells.", "url": "https://www.nature.com/articles/s41563-026-02534-5", "date": "2026-04-16", "published_at": "2026-04-16T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Healthcare Logistics Market Trends and Investment Opportunities 2026-2030 with Strategic Analysis of Key Players", "description": "Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The \"Healthcare Logistics Market 2026-2030\" has been added to ResearchAndMarkets.com's offering. The...", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274741/28124/en/Healthcare-Logistics-Market-Trends-and-Investment-Opportunities-2026-2030-with-Strategic-Analysis-of-Key-Players.html", "date": "2026-04-15", "published_at": "2026-04-15T16:16:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Animal Health Market Intelligence Report 2026-2034 Featuring Strategic Analysis of Bayer, Elanco, Merck, Merial, Zoetis, Boehringer Ingelheim, Ceva Sante Animale, Heska and More", "description": "The animal health market offers opportunities in preventive healthcare, biotechnology, and telemedicine. Rising zoonotic diseases spur demand for vaccines and diagnostics. Pet humanization drives specialized care and high-quality pet products. North America l…", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274681/28124/en/Animal-Health-Market-Intelligence-Report-2026-2034-Featuring-Strategic-Analysis-of-Bayer-Elanco-Merck-Merial-Zoetis-Boehringer-Ingelheim-Ceva-Sante-Animale-Heska-and-More.html", "date": "2026-04-15", "published_at": "2026-04-15T15:16:00Z", "sentiment": { "label": "positive", "score": 0.813, "confidence": 0.81 } }, { "source": "news", "source_name": "Plos.org", "title": "Circadian rhythms remain temperature compensated during a Q neuron–induced hibernation-like state in mice", "description": "The circadian clock maintains a nearly constant period across temperatures, but to what extent temperature compensation operates in mammals during deep hypothermia is unknown. This study shows that mice maintain circadian rhythms during a hibernation-like hyp…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003475", "date": "2026-04-15", "published_at": "2026-04-15T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "NSUN4-mediated m5C RNA methylation protects retinal cells against excitotoxic injury via the SHH signaling pathway", "description": "Glaucoma, a leading global cause of blindness, is characterized by progressive retinal neuronal loss. NOP2/Sun RNA methyltransferase 4 (NSUN4), a writer of 5-methylcytosine (m5C) RNA modifications, has established roles in methylation and mitoribosome assembl…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347414", "date": "2026-04-15", "published_at": "2026-04-15T14:00:00Z", "sentiment": { "label": "negative", "score": -0.621, "confidence": 0.62 } }, { "source": "news", "source_name": "Plos.org", "title": "Evaluation of therapeutic efficacy of baloxavir marboxil against high pathogenicity avian influenza virus infection in duck model", "description": "High pathogenicity avian influenza virus (HPAIV) infections have been frequently reported in wild birds since 2020. Because HPAIV infection has occasionally caused outbreaks in captive rare birds, treatment using antiviral drugs has been considered from the p…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347205", "date": "2026-04-15", "published_at": "2026-04-15T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Phosphorous Trichloride Market Size to Hit USD 4.46 Billion by 2035 | SNS Insider", "description": "The phosphorous trichloride market is growing steadily due to increasing demand for phosphorus-based intermediates in agrochemicals, pharmaceuticals, and flame retardants, supported by expanding crop protection needs and rising adoption across industrial appl…", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274273/0/en/Phosphorous-Trichloride-Market-Size-to-Hit-USD-4-46-Billion-by-2035-SNS-Insider.html", "date": "2026-04-15", "published_at": "2026-04-15T10:30:00Z", "sentiment": { "label": "positive", "score": 0.361, "confidence": 0.36 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Rapid Diagnostic Tests Market Size is Expected to reach USD 67.83 Billion by 2035 Owing to the Increasing Number of Infections Globally | SNS Insider", "description": "Rapid diagnostic tests market grows with rising infections, home testing adoption, driven by tech advances, fast results, and expanding healthcare access....", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274218/0/en/Rapid-Diagnostic-Tests-Market-Size-is-Expected-to-reach-USD-67-83-Billion-by-2035-Owing-to-the-Increasing-Number-of-Infections-Globally-SNS-Insider.html", "date": "2026-04-15", "published_at": "2026-04-15T09:30:00Z", "sentiment": { "label": "positive", "score": 0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Nanotechnology Market to Grow at 13.21% CAGR to Reach USD 220.8 Billion by 2031, Supported by Healthcare Expansion and Clean Energy Initiatives, Reports Mordor Intelligence", "description": "The global nanotechnology market is driven by demand for advanced materials, expanding healthcare applications, and increasing R&D investments, with Asia-Pacific as the largest region. The global nanotechnology market is driven by demand for advanced material…", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274161/0/en/Nanotechnology-Market-to-Grow-at-13-21-CAGR-to-Reach-USD-220-8-Billion-by-2031-Supported-by-Healthcare-Expansion-and-Clean-Energy-Initiatives-Reports-Mordor-Intelligence.html", "date": "2026-04-15", "published_at": "2026-04-15T07:35:00Z", "sentiment": { "label": "positive", "score": 0.883, "confidence": 0.88 } }, { "source": "news", "source_name": "Nature.com", "title": "A series of spontaneously blinking dyes for super-resolution microscopy", "description": "A series of spontaneously blinking dyes in the far-red range facilitate single-molecule localization microscopy. These dyes vary in their blinking properties and can be matched to the applications and microscopy modalities as needed.", "url": "https://www.nature.com/articles/s41592-026-03062-5", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration", "description": "A new cerebrospinal fluid biomarker, AcTau174, was elevated in frontotemporal lobar degeneration with TAR DNA-binding protein (FTLD-TDP), distinguishing this pathology from FTLD-Tau, and was associated with disease severity and progression in FTLD-TDP.", "url": "https://www.nature.com/articles/s41591-026-04341-6", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Template-driven scaffolding of SCFFBXO42 regulates PP2A degradation", "description": "The E3 ligase SCFFBXO42 degrades holoenzyme-free PP2Ac in complex with the coiled-coil protein CCDC6 to maintain cancer cell fitness", "url": "https://www.nature.com/articles/s41586-026-10368-z", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "negative", "score": -0.869, "confidence": 0.87 } }, { "source": "news", "source_name": "Nature.com", "title": "Cell-type-targeted mitochondrial transplantation rescues cell degeneration", "description": "MitoCatch is a cell-type-specific mitochondrion-targeting system that links mitochondria and the cell surface by protein binders and delivers mitochondria into the target cell.", "url": "https://www.nature.com/articles/s41586-026-10391-0", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "Nature.com", "title": "The neural mechanisms supporting the rise and fall of maternal aggression", "description": "In mice, female aggression is governed by an amygdala–to–medial hypothalamus circuit that is strengthened during pregnancy and is dynamically amplified by oxytocin during lactation.", "url": "https://www.nature.com/articles/s41586-026-10354-5", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "Nature.com", "title": "Artificial allosteric protein switches with machine-learning-designed receptors", "description": "Allosteric biosensors are constructed by combining reporter proteins with machine-learning-designed receptor domains.", "url": "https://www.nature.com/articles/s41587-026-03081-9", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes", "description": "For individuals with APOL1 high-risk genotypes, which are enriched in individuals of African ancestry, a nine-protein proteomic risk score enables early prediction of kidney disease progression and may, thereby, enable early intervention.", "url": "https://www.nature.com/articles/s41591-026-04337-2", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "negative", "score": -0.494, "confidence": 0.49 } }, { "source": "news", "source_name": "Nature.com", "title": "Development of the fluorescent probe CenSpark for labeling centrioles and cilia", "description": "CenSpark is a dual-ligand fluorescent probe binding simultaneously inner and outer microtubule sites, a configuration unique to doublet and triplet microtubules, enabling selective live imaging of centrioles and cilia across species.", "url": "https://www.nature.com/articles/s41589-026-02186-1", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Archinect", "title": "Practicing design in an uncertain future: Design Practice and Interior Design at the Royal College of Art", "description": "This post is brought to you by Royal College of Art (RCA) At the Royal College of Art (RCA), design education is shaped by an engagement with the complexities of contemporary life, from the built environment to the spaces we inhabit daily. Two programmes with…", "url": "https://archinect.com/news/article/150535544/practicing-design-in-an-uncertain-future-design-practice-and-interior-design-at-the-royal-college-of-art", "date": "2026-04-14", "published_at": "2026-04-14T16:46:00Z", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Research Report 2026: $8.77 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "description": "Key market opportunities include the increasing demand for scalable DNA manufacturing, integration with personalized medicine, and rising adoption of DNA-based data storage. The focus is on high-precision, environmentally sustainable synthesis methods, with i…", "url": "https://www.globenewswire.com/news-release/2026/04/14/3273690/28124/en/Enzymatic-Deoxyribonucleic-Acid-DNA-Synthesis-Technology-Research-Report-2026-8-77-Bn-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html", "date": "2026-04-14", "published_at": "2026-04-14T15:28:00Z", "sentiment": { "label": "positive", "score": 0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Messenger Ribo Nucleic Acid (mRNA) Vaccine Contract Development and Manufacturing Organization (CDMO) Market Research and Global Forecast Report 2026-2035", "description": "The mRNA vaccine CDMO market is rapidly expanding, driven by growing biotech startups, limited in-house manufacturing, and increasing demand for rapid vaccine production in response to infectious diseases. Opportunities include personalized mRNA cancer vaccin…", "url": "https://www.globenewswire.com/news-release/2026/04/14/3273664/28124/en/Messenger-Ribo-Nucleic-Acid-mRNA-Vaccine-Contract-Development-and-Manufacturing-Organization-CDMO-Market-Research-and-Global-Forecast-Report-2026-2035.html", "date": "2026-04-14", "published_at": "2026-04-14T15:03:00Z", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Neion Bio Strengthens Genome Engineering Leadership with Appointment of Colossal Biosciences Veteran James Kehler", "description": "Neion Bio names Colossal Biosciences veteran James Kehler as Head of Avian Sciences, strengthening its genome engineering leadership....", "url": "https://www.globenewswire.com/news-release/2026/04/14/3273561/0/en/Neion-Bio-Strengthens-Genome-Engineering-Leadership-with-Appointment-of-Colossal-Biosciences-Veteran-James-Kehler.html", "date": "2026-04-14", "published_at": "2026-04-14T14:00:00Z", "sentiment": { "label": "positive", "score": 0.535, "confidence": 0.54 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Western Blotting Market Size is Poised to Reach USD 4.38 Billion by 2035 Caused by the Surging Use of Protein Analysis for Diagnostic Purposes Globally | SNS Insider", "description": "Western blotting market grows with rising disease diagnostics demand, and automation, driven by research expansion and protein analysis needs....", "url": "https://www.globenewswire.com/news-release/2026/04/14/3273152/0/en/Western-Blotting-Market-Size-is-Poised-to-Reach-USD-4-38-Billion-by-2035-Caused-by-the-Surging-Use-of-Protein-Analysis-for-Diagnostic-Purposes-Globally-SNS-Insider.html", "date": "2026-04-14", "published_at": "2026-04-14T10:28:00Z", "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Cell Line Development Market to Reach $8.95 Bn by 2031 with Gene & Cell Therapy Manufacturing Growing at 10.88% CAGR, Says Mordor Intelligence", "description": "Cell line development market driven by biologics, mAbs and gene therapies, with innovation and automation led by Thermo Fisher, Merck, Danaher, Lonza....", "url": "https://www.globenewswire.com/news-release/2026/04/14/3273032/0/en/Cell-Line-Development-Market-to-Reach-8-95-Bn-by-2031-with-Gene-Cell-Therapy-Manufacturing-Growing-at-10-88-CAGR-Says-Mordor-Intelligence.html", "date": "2026-04-14", "published_at": "2026-04-14T07:26:00Z", "sentiment": { "label": "positive", "score": 0.958, "confidence": 0.96 } }, { "source": "news", "source_name": "Nature.com", "title": "Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy", "description": "Two individuals with KCNT1-related epileptic encephalopathy were treated with a KCNT1-targeting antisense oligonucleotide, leading to significant reductions in seizure frequency and intensity, but also the development of hydrocephalus.", "url": "https://www.nature.com/articles/s41591-026-04314-9", "date": "2026-04-14", "published_at": "2026-04-14T00:00:00Z", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "Royal Society of Chemistry", "title": "Computational Insights into the Hydroxylation Mechanism of Toluene Catalyzed by Non-Heme Diiron Toluene 4-Monooxygenase T4moH", "description": "Phys. Chem. Chem. Phys., 2026, Accepted ManuscriptDOI: 10.1039/D6CP01064D, PaperZheng Liang, Yue Wang, Yongjun LiuToluene monooxygenases (TMOs) are kind of diiron enzymes that catalyze the hydroxylation of aromatic rings. Four representative systems have been…", "url": "https://pubs.rsc.org/en/content/articlelanding/2026/cp/d6cp01064d", "date": "2026-04-13", "published_at": "2026-04-13T23:00:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Geektells.com", "title": "John Martellaro, RIP", "description": "John Martellaro has passed away, and I wanted to take a moment to remember him. He was one of the best people I knew.", "url": "https://geektells.com/john-martellaro-remembrance/", "date": "2026-04-13", "published_at": "2026-04-13T19:49:32Z", "sentiment": { "label": "positive", "score": 0.637, "confidence": 0.64 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Companion Diagnostics Market Size is Projected to Hit USD 26.38 Billion by 2035 – SNS Insider", "description": "Precision Medicine Revolution and Rising Cancer Prevalence Drive 11.9% CAGR as Healthcare Shifts Toward Targeted Therapies. Precision Medicine Revolution and Rising Cancer Prevalence Drive 11.9% CAGR as Healthcare Shifts Toward Targeted Therapies.", "url": "https://www.globenewswire.com/news-release/2026/04/13/3272705/0/en/Companion-Diagnostics-Market-Size-is-Projected-to-Hit-USD-26-38-Billion-by-2035-SNS-Insider.html", "date": "2026-04-13", "published_at": "2026-04-13T15:30:00Z", "sentiment": { "label": "negative", "score": -0.869, "confidence": 0.87 } }, { "source": "news", "source_name": "Plos.org", "title": "Poxvirus A52 protein subverts autophagy flux by blocking autophagosome–lysosome fusion to promote viral replication", "description": "Author summary Many poxviruses are zoonotic pathogens that threaten public health. Autophagy is a delicately regulated process within cells. Nevertheless, the relationship between poxviruses and host cell autophagy remains ambiguous. Here, we show that VACV i…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014137", "date": "2026-04-13", "published_at": "2026-04-13T14:00:00Z", "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "Plos.org", "title": "Microbiota-derived indole differentially shapes Entamoeba histolytica physiology and promotes host-compatible colonization", "description": "Author summary Entamoeba histolytica is a protozoan parasite that colonizes the human large intestine and causes amoebiasis, a disease that can range from mild diarrhea to severe invasive colitis and, in some cases, liver abscess. In the gut, the parasite enc…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013416", "date": "2026-04-13", "published_at": "2026-04-13T14:00:00Z", "sentiment": { "label": "negative", "score": -0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "Plos.org", "title": "Chronic replication stress-mediated genomic instability disrupts placenta development in mice", "description": "Author summary Proper placental development is essential for the health of both the mother and the fetus during pregnancy. In this study, we show that genetic defects in the DNA replication machinery - resulting in genomic instability - can disrupt placental …", "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1012111", "date": "2026-04-13", "published_at": "2026-04-13T14:00:00Z", "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - Global Forecast to 2031", "description": "The allergy diagnostic market is set to surge, projected to reach USD 10.77 billion by 2030 from USD 6.80 billion in 2025, at a CAGR of 9.6%. Technological innovation in diagnostics, such as multiplex immunoassays and molecular allergology, drives this growth…", "url": "https://www.globenewswire.com/news-release/2026/04/13/3272461/28124/en/Allergy-Diagnostic-Market-by-Product-Service-Test-Type-Allergen-End-User-Global-Forecast-to-2031.html", "date": "2026-04-13", "published_at": "2026-04-13T12:00:00Z", "sentiment": { "label": "positive", "score": 0.602, "confidence": 0.6 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Drug Screening Market Research and Global Forecast Report 2025-2030: Opportunities Expand with Oral Fluid Adoption, Fingerprint-Based Workplace Testing and Emerging Market Growth", "description": "The global drug screening market is poised to grow from USD 10.36 billion in 2025 to USD 21.29 billion by 2030, at a CAGR of 15.5%, driven by stricter regulations and increased testing across safety-sensitive sectors. As substance use rises globally, with ove…", "url": "https://www.globenewswire.com/news-release/2026/04/13/3272311/28124/en/Drug-Screening-Market-Research-and-Global-Forecast-Report-2025-2030-Opportunities-Expand-with-Oral-Fluid-Adoption-Fingerprint-Based-Workplace-Testing-and-Emerging-Market-Growth.html", "date": "2026-04-13", "published_at": "2026-04-13T10:21:00Z", "sentiment": { "label": "positive", "score": 0.863, "confidence": 0.86 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Cell Therapy Technology Market Research and Global Forecast Report 2025-2030: Rising Chronic Disease Burden and CRISPR-Driven Gene Editing Innovations Driving Growth", "description": "The global cell therapy technologies market is set to grow from USD 4.41 billion in 2025 to USD 7.91 billion by 2030, achieving a CAGR of 12.4%. Key growth drivers include advancements in regenerative medicine, increasing chronic disease prevalence, robust R&…", "url": "https://www.globenewswire.com/news-release/2026/04/13/3272308/28124/en/Cell-Therapy-Technology-Market-Research-and-Global-Forecast-Report-2025-2030-Rising-Chronic-Disease-Burden-and-CRISPR-Driven-Gene-Editing-Innovations-Driving-Growth.html", "date": "2026-04-13", "published_at": "2026-04-13T10:11:00Z", "sentiment": { "label": "positive", "score": 0.772, "confidence": 0.77 } }, { "source": "news", "source_name": "Nature.com", "title": "Lipid-trap mass spectrometry identifies lipid–protein interactions in cells", "description": "Paquola et al. present a technique named lipid-trap mass spectrometry (LTMS) to study lipid–protein interactions directly captured from mammalian cells.", "url": "https://www.nature.com/articles/s41556-026-01928-6", "date": "2026-04-13", "published_at": "2026-04-13T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "The Irish Times", "title": "Bordeaux beat Toulouse to reach Champions Cup semi-final against Bath", "description": "Reigning champions put four tries past Top 14 rivals to reach final four", "url": "https://www.irishtimes.com/sport/rugby/2026/04/12/bordeaux-beat-toulouse-to-reach-champions-cup-semi-final-against-bath/", "date": "2026-04-12", "published_at": "2026-04-12T16:52:38Z", "sentiment": { "label": "positive", "score": 0.832, "confidence": 0.83 } }, { "source": "news", "source_name": "RTE", "title": "Bordeaux beat Toulouse to reach Champions Cup semi-finals", "description": "Investec Champions Cup holders Bordeaux battled past Toulouse 30-15 to set up a semi-final against Bath.", "url": "https://www.rte.ie/sport/rugby/2026/0412/1567801-bordeaux-beat-toulouse-to-reach-champions-cup-semi-finals/", "date": "2026-04-12", "published_at": "2026-04-12T16:18:19Z", "sentiment": { "label": "positive", "score": 0.691, "confidence": 0.69 } }, { "source": "news", "source_name": "BBC News", "title": "Dragons beat Zebre to set up Montpellier semi-final", "description": "Dragons reach a European Challenge Cup semi-final for the first time in 10 years by defeating Zebre 35-32 in the quarter-final in Parma.", "url": "https://www.bbc.com/sport/rugby-union/articles/c8ej51ej47yo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-11", "published_at": "2026-04-11T21:04:53Z", "sentiment": { "label": "negative", "score": -0.296, "confidence": 0.3 } }, { "source": "news", "source_name": "BBC News", "title": "Scotland celebrate hard-fought victory over Wales", "description": "Scotland begin a new era under Sione Fukofuka with a 24-19 victory over Wales in Cardiff in the opening round of the Women's Six Nations.", "url": "https://www.bbc.com/sport/rugby-union/articles/c9vlxj83dnwo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-11", "published_at": "2026-04-11T17:55:02Z", "sentiment": { "label": "positive", "score": 0.572, "confidence": 0.57 } }, { "source": "news", "source_name": "BBC News", "title": "Scotland celebrate hard-fought victory over Wales", "description": "Scotland begin a new era under Sione Fukofuka with a 24-19 victory over Wales in Cardiff in the opening round of the Women's Six Nations.", "url": "https://www.bbc.com/sport/rugby-union/articles/c9vlxj83dnwo", "date": "2026-04-11", "published_at": "2026-04-11T17:54:56Z", "sentiment": { "label": "positive", "score": 0.572, "confidence": 0.57 } }, { "source": "news", "source_name": "The Irish Times", "title": "England too strong for Ireland in Women’s Six Nations opener in Twickenham", "description": "An improved second half showing will encourage Ireland ahead of game against Italy", "url": "https://www.irishtimes.com/sport/rugby/2026/04/11/england-too-strong-for-ireland-in-womens-six-nations-opener-in-twickenham/", "date": "2026-04-11", "published_at": "2026-04-11T15:38:48Z", "sentiment": { "label": "positive", "score": 0.866, "confidence": 0.87 } }, { "source": "news", "source_name": "PR Newswire UK", "title": "Global Metabolomics Market Poised for Strong Growth as Advancements in Precision Medicine and Biomarker Discovery Accelerate Adoption: Verified Market Research®", "description": "The global metabolomics market is witnessing steady expansion driven by rising demand for precision medicine, biomarker discovery, and systems biology research. Technological advancements in mass spectrometry and nuclear magnetic resonance (NMR), coupled with…", "url": "https://www.prnewswire.co.uk/news-releases/global-metabolomics-market-poised-for-strong-growth-as-advancements-in-precision-medicine-and-biomarker-discovery-accelerate-adoption-verified-market-research-302739224.html", "date": "2026-04-10", "published_at": "2026-04-10T16:52:00Z", "sentiment": { "label": "positive", "score": 0.951, "confidence": 0.95 } }, { "source": "news", "source_name": "Plos.org", "title": "Casein kinase 2-mediated phosphorylation of the splicing factor SF3B3 plays a key role in esophageal squamous cell carcinoma progression", "description": "Protein kinases play a crucial role in regulating cellular processes, and their dysregulation is frequently implicated in various diseases, including cancer. This study shows that casein kinase 2-mediated phosphorylation of the splicing factor SF3B2 enhances …", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003729", "date": "2026-04-10", "published_at": "2026-04-10T14:00:00Z", "sentiment": { "label": "negative", "score": -0.25, "confidence": 0.25 } }, { "source": "news", "source_name": "Plos.org", "title": "Structural insights into subtype-specific agonist recognition by sphingosine-1-phosphate receptors", "description": "Sphingosine-1-phosphate receptors (S1PRs) play complex roles in several pathological processes, which has led to the development of pharmacological modulators. This study solves the cryo-EM structures of four agonist-bound S1PR1-Gi1 complexes and reveals the …", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003381", "date": "2026-04-10", "published_at": "2026-04-10T14:00:00Z", "sentiment": { "label": "positive", "score": 0.542, "confidence": 0.54 } }, { "source": "news", "source_name": "Plos.org", "title": "Cytotoxic Vδ2+ T cell subsets expand in response to malaria in human tonsil and spleen organoids", "description": "Author summary Plasmodium falciparum (Pf) malaria vaccines are significantly less effective in populations with endemic malaria exposure compared to malaria-naïve individuals. We used human tonsil and spleen organoids to investigate whether Pf infection alter…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013565", "date": "2026-04-10", "published_at": "2026-04-10T14:00:00Z", "sentiment": { "label": "positive", "score": 0.626, "confidence": 0.63 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Immunohistochemistry Market Led by Diagnostics Segment with 60%+ Share; Market Projected to Reach USD 4.42 billion by 2031, Mordor Intelligence Reports", "description": "Immunohistochemistry demand grows in oncology diagnostics and digital pathology as companies like Thermo Fisher, Roche, Agilent and Merck drive innovation.", "url": "https://www.globenewswire.com/news-release/2026/04/10/3271669/0/en/Immunohistochemistry-Market-Led-by-Diagnostics-Segment-with-60-Share-Market-Projected-to-Reach-USD-4-42-billion-by-2031-Mordor-Intelligence-Reports.html", "date": "2026-04-10", "published_at": "2026-04-10T11:14:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "Singletracks.com", "title": "The Monarch Crest Trail’s doubletrack downhill is being replaced with 1.8 miles of singletrack", "description": "After years of losing precious vert on a dusty mining road, riders will soon have a purpose-built singletrack descent wrapping around the flanks of Mount Ouray.\nThe article The Monarch Crest Trail’s doubletrack downhill is being replaced with 1.8 miles of sin…", "url": "https://www.singletracks.com/?p=716032", "date": "2026-04-10", "published_at": "2026-04-10T10:02:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision Medicine", "description": "Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The \"Next-Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application - Global Forecast to 2030\" has been added to ResearchAndMarkets.com's offering.The next-generation sequencing (NGS) …", "url": "https://www.globenewswire.com/news-release/2026/04/10/3271604/28124/en/Global-Next-Generation-Sequencing-NGS-Market-to-Double-in-Size-by-2030-Asia-Pacific-NGS-Market-Poised-for-Fastest-Growth-Driven-by-Large-Scale-Genomic-Projects-and-the-Rising-Need-.html", "date": "2026-04-10", "published_at": "2026-04-10T09:45:00Z", "sentiment": { "label": "positive", "score": 0.557, "confidence": 0.56 } }, { "source": "news", "source_name": "Pypi.org", "title": "teradatamodelops 7.2.6", "description": "Python client for Teradata ModelOps (TMO)", "url": "https://pypi.org/project/teradatamodelops/7.2.6/", "date": "2026-04-09", "published_at": "2026-04-09T22:43:16Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Pypi.org", "title": "teradatamodelops 7.2.5", "description": "Python client for Teradata ModelOps (TMO)", "url": "https://pypi.org/project/teradatamodelops/7.2.5/", "date": "2026-04-09", "published_at": "2026-04-09T19:40:52Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Cdc.gov", "title": "Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023", "description": "This report describes the emergence of drug-resistant shigellosis in the United States during 2011-2023.", "url": "https://www.cdc.gov/mmwr/volumes/75/wr/mm7513a1.htm", "date": "2026-04-09", "published_at": "2026-04-09T17:00:00Z", "sentiment": { "label": "positive", "score": 0.681, "confidence": 0.68 } }, { "source": "news", "source_name": "RTE", "title": "W6N: England v Ireland - All You Need to Know", "description": "It's been a long old wait since last year's Rugby World Cup, and what a way to kick off this Guinness Women's Six Nations.", "url": "https://www.rte.ie/sport/rugby/2026/0409/1567428-w6n-england-v-ireland-all-you-need-to-know/", "date": "2026-04-09", "published_at": "2026-04-09T14:23:13Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology", "description": "Market growth is driven by rising cancer prevalence, demand for minimally invasive procedures, and advances in precision diagnostics....", "url": "https://www.globenewswire.com/news-release/2026/04/09/3271135/0/en/Global-Noninvasive-Cancer-Diagnostics-Market-to-Reach-165-2-Billion-by-2030-as-Liquid-Biopsy-AI-Enabled-Screening-and-Multi-Cancer-Detection-Tests-Transform-Oncology.html", "date": "2026-04-09", "published_at": "2026-04-09T14:12:00Z", "sentiment": { "label": "negative", "score": -0.823, "confidence": 0.82 } }, { "source": "news", "source_name": "Plos.org", "title": "Antibacterial potential of epiphytic fungi obtained from brown algae of Kenyan coastal waters", "description": "The rapid rise of antimicrobial resistance, coupled with the limited development of new therapeutic agents, is a critical public health concern that needs urgent and innovative interventions. Marine fungi represent an important but still largely unexplored so…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346865", "date": "2026-04-09", "published_at": "2026-04-09T14:00:00Z", "sentiment": { "label": "positive", "score": 0.166, "confidence": 0.17 } }, { "source": "news", "source_name": "Plos.org", "title": "Accumulation of mutations in nsp4, E, and the S2 subunit underlies mammalian cell tropism expansion and virulence attenuation of avian coronavirus", "description": "Author summary Infectious bronchitis virus (IBV), a member of the γ-coronavirus genus, is primarily controlled via live attenuated vaccines. However, the production of these vaccines depends on embryonated chicken eggs, which are plagued by supply constraints…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014147", "date": "2026-04-09", "published_at": "2026-04-09T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Whole genome and phylogenomic insights into Vibrio parahaemolyticus from Pacific White Shrimp reveal resistance and virulence traits in Bangladeshi aquaculture", "description": "The fisheries sector of Bangladesh has significantly contributed to the national economy and provided livelihoods for millions of rural households. However, disease outbreaks and contamination of fish by Vibrio species pose significant hurdles to production a…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346962", "date": "2026-04-09", "published_at": "2026-04-09T14:00:00Z", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages", "description": "AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage\r\n: As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond traditional quality assurance systems toward a…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270963/0/en/AI-Powered-Pharma-Manufacturing-Signals-Scalable-Efficiency-Long-Term-Cost-Advantages.html", "date": "2026-04-09", "published_at": "2026-04-09T12:30:00Z", "sentiment": { "label": "positive", "score": 0.751, "confidence": 0.75 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Indoor Air Quality Monitor Market Size to Grow $11.84 Billion by 2035 | SNS Insider", "description": "Indoor Air Quality Monitor Market Size, Share, Trends & Segment, by Pollutant Type, Product Type, Technology, End User, and Region | Global Forecast 2035...", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270813/0/en/Indoor-Air-Quality-Monitor-Market-Size-to-Grow-11-84-Billion-by-2035-SNS-Insider.html", "date": "2026-04-09", "published_at": "2026-04-09T11:30:00Z", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics", "description": "The biopharmaceutical CXO market offers opportunities in strategic outsourcing, digital integration, resilient supply chains, and value-driven partnerships amidst evolving regulatory landscapes. The biopharmaceutical CXO market offers opportunities in strateg…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270735/28124/en/1-05-Bn-Biopharmaceutical-CXO-Markets-Global-Forecast-Report-2026-2032-How-Leading-Pharmas-Such-as-Pfizer-Roche-Novartis-Sanofi-and-AstraZeneca-Navigate-the-Evolving-Dynamics.html", "date": "2026-04-09", "published_at": "2026-04-09T10:05:00Z", "sentiment": { "label": "positive", "score": 0.943, "confidence": 0.94 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Active Pharmaceutical Ingredients CDMO Market Research and Global Forecast Report 2025-2032: Exploring Service Models, Analytical Services, Process Developments, and More", "description": "The API CDMO market presents opportunities in outsourcing, flexible solutions, and strategic partnerships, driven by regulatory complexity, technology adoption, and shifting supplier dynamics. The API CDMO market presents opportunities in outsourcing, flexibl…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270705/28124/en/Active-Pharmaceutical-Ingredients-CDMO-Market-Research-and-Global-Forecast-Report-2025-2032-Exploring-Service-Models-Analytical-Services-Process-Developments-and-More.html", "date": "2026-04-09", "published_at": "2026-04-09T09:09:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032", "description": "New therapies and regulations are redefining biopharma logistics, creating opportunities in cold chain integrity, digital tracking, and strategic vendor collaborations globally. New therapies and regulations are redefining biopharma logistics, creating opport…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270697/28124/en/Biopharmaceutical-Third-Party-Logistics-Distribution-Management-Packaging-Labeling-Transportation-Warehousing-Market-Research-and-Global-Forecast-Report-2026-2032.html", "date": "2026-04-09", "published_at": "2026-04-09T08:49:00Z", "sentiment": { "label": "positive", "score": 0.883, "confidence": 0.88 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Pharma B2B ECommerce Global Market Forecast 2026-2032 - Opportunities Lie in Digital Integration, Resilient Supply Chains, Real-time Transparency, and Compliance", "description": "The market opportunities lie in digital integration, resilient supply chains, real-time transparency, and compliance through technology, enabling dynamic, scalable, and efficient B2B pharmaceutical operations. The market opportunities lie in digital integrati…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270685/28124/en/Pharma-B2B-ECommerce-Global-Market-Forecast-2026-2032-Opportunities-Lie-in-Digital-Integration-Resilient-Supply-Chains-Real-time-Transparency-and-Compliance.html", "date": "2026-04-09", "published_at": "2026-04-09T08:02:00Z", "sentiment": { "label": "positive", "score": 0.904, "confidence": 0.9 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Flow Cytometry Market Set to Surpass USD 12.19 Billion by 2035, Driven by Rising Demand for Precision Diagnostics – SNS Insider", "description": "Austin, United States, April 08, 2026 (GLOBE NEWSWIRE) -- SNS Insider reported that global Flow Cytometry Market was valued at USD 5.75 billion in 2025 and is expected to reach USD 12.19 billion by 2035, growing at a CAGR of 7.8% over the forecast period of 2…", "url": "https://www.globenewswire.com/news-release/2026/04/08/3270347/0/en/Flow-Cytometry-Market-Set-to-Surpass-USD-12-19-Billion-by-2035-Driven-by-Rising-Demand-for-Precision-Diagnostics-SNS-Insider.html", "date": "2026-04-08", "published_at": "2026-04-08T15:33:00Z", "sentiment": { "label": "positive", "score": 0.718, "confidence": 0.72 } }, { "source": "news", "source_name": "Plos.org", "title": "Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both in vivo and in vitro infection", "description": "Author summary Hepatitis C virus (HCV) infects millions of people and causes severe liver diseases, yet vaccine development has been hindered by the lack of practical small-animal models with intact immunity. Hepacivirus ratti (NRHV1), a close relative of HCV…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014127", "date": "2026-04-08", "published_at": "2026-04-08T14:00:00Z", "sentiment": { "label": "negative", "score": -0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "Plos.org", "title": "Cetacean coronavirus spikes highlight S glycoprotein structural plasticity", "description": "Author summary Coronaviruses are well known for their ability to jump between species, a process driven mainly by the spike protein on their surface. In this study, we examined spike proteins from coronaviruses found in marine mammals (whales and dolphins) to…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013855", "date": "2026-04-08", "published_at": "2026-04-08T14:00:00Z", "sentiment": { "label": "positive", "score": 0.7, "confidence": 0.7 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biopharmaceuticals Contract Manufacturing Market Global Forecast Report 2026-2032: A Cornerstone for Operational Efficiency, Agility, and Strategic Focus Amid a Rapidly Evolving Therapeutic Landscape", "description": "Biopharma contract manufacturing offers strategic agility, innovation in automation, regional diversification, and scalable solutions, enhancing market entry and supply chain resilience. Biopharma contract manufacturing offers strategic agility, innovation in…", "url": "https://www.globenewswire.com/news-release/2026/04/08/3269903/28124/en/Biopharmaceuticals-Contract-Manufacturing-Market-Global-Forecast-Report-2026-2032-A-Cornerstone-for-Operational-Efficiency-Agility-and-Strategic-Focus-Amid-a-Rapidly-Evolving-Thera.html", "date": "2026-04-08", "published_at": "2026-04-08T09:41:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Pharmaceutical Excipient Market - Global Forecast 2026-2032: Growth Driven by Innovation, Compliance Needs, and Digital Procurement with Emphasis on Supply Resilience, and Sustainability,", "description": "Excipient market growth driven by innovation, compliance needs, and digital procurement, with emphasis on supply resilience, sustainability, and adaptation to tariff changes. Excipient market growth driven by innovation, compliance needs, and digital procurem…", "url": "https://www.globenewswire.com/news-release/2026/04/08/3269875/28124/en/Pharmaceutical-Excipient-Market-Global-Forecast-2026-2032-Growth-Driven-by-Innovation-Compliance-Needs-and-Digital-Procurement-with-Emphasis-on-Supply-Resilience-and-Sustainability.html", "date": "2026-04-08", "published_at": "2026-04-08T09:07:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Saturation editing of RNU4-2 reveals distinct dominant and recessive disorders", "description": "Saturation genome editing of RNU4-2 identifies the functional and clinical impact of variants across the entire gene and delineates variants that cause a new recessive neurodevelopmental disorder distinct from ReNU syndrome.", "url": "https://www.nature.com/articles/s41586-026-10334-9", "date": "2026-04-08", "published_at": "2026-04-08T00:00:00Z", "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "Nature.com", "title": "Synthetic super-enhancers enable precision viral immunotherapy", "description": "Synthetic super-enhancers enable specific delivery of anticancer payloads, achieving tumour elimination after a single dose in a mouse model of aggressive glioblastoma.", "url": "https://www.nature.com/articles/s41586-026-10329-6", "date": "2026-04-08", "published_at": "2026-04-08T00:00:00Z", "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "Mjtsai.com", "title": "John Martellaro, RIP", "description": "Bryan Chaffin: He rose to the rank of Captain in the U.S. Air Force, and he was a NASA scientist. He worked for years at Apple, and most importantly to me, he was a columnist and the voice of reason and humanity at The Mac Observer. He wrote SciFi and a varie…", "url": "https://mjtsai.com/blog/2026/04/07/john-martellaro-rip/", "date": "2026-04-07", "published_at": "2026-04-07T22:53:20Z", "sentiment": { "label": "positive", "score": 0.38, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications", "description": "Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand....", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269543/0/en/Global-DNA-Read-Write-and-Edit-Market-to-Surge-to-67-7-Billion-by-2030-Driven-by-CRISPR-Advances-Genomic-Diagnostics-and-Expanding-Clinical-Applications.html", "date": "2026-04-07", "published_at": "2026-04-07T17:44:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Rapid Growth in Cell-Free Tumor DNA Detection Market: Forecast to Reach $5.64 Billion by 2030 as Advancements in Personalized Medicine Propel Expansion", "description": "Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The \"Cell Free Tumor Deoxyribonucleic Acid (DNA) Detection Market Report 2026\" has been added to ResearchAndMarkets.com's offering.", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269503/28124/en/Rapid-Growth-in-Cell-Free-Tumor-DNA-Detection-Market-Forecast-to-Reach-5-64-Billion-by-2030-as-Advancements-in-Personalized-Medicine-Propel-Expansion.html", "date": "2026-04-07", "published_at": "2026-04-07T16:23:00Z", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Molecular Tumor Board Solutions Market Outlook 2026-2030 & 2035 with Competitor Market Share Data", "description": "Key growth factors include expanding precision oncology programs, genomic data integration, and cloud deployment in healthcare, with strong potential in Asia-Pacific Key growth factors include expanding precision oncology programs, genomic data integration, a…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269500/28124/en/Molecular-Tumor-Board-Solutions-Market-Outlook-2026-2030-2035-with-Competitor-Market-Share-Data.html", "date": "2026-04-07", "published_at": "2026-04-07T16:15:00Z", "sentiment": { "label": "positive", "score": 0.832, "confidence": 0.83 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Biopreservation Market Analysis by Product Type, Application, End User, and Region, 2025-2035: Cell and Gene Therapies Drive Biopreservation Demand", "description": "Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The \"Biopreservation Market - A Global and Regional Analysis: Product Type, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering.", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269491/28124/en/Global-Biopreservation-Market-Analysis-by-Product-Type-Application-End-User-and-Region-2025-2035-Cell-and-Gene-Therapies-Drive-Biopreservation-Demand.html", "date": "2026-04-07", "published_at": "2026-04-07T16:04:00Z", "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "news", "source_name": "Plos.org", "title": "Multifaceted bioactivity of brown seaweed-derived fucoidan from the Indian Coastline: A natural health product candidate", "description": "Brown seaweeds are rich in bioactive constituents, among which fucoidan a sulphated polysaccharide is particularly noted for its broad-spectrum therapeutic properties. This study explores the multifaceted bioactivity of fucoidan extracted from six brown seawe…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346712", "date": "2026-04-07", "published_at": "2026-04-07T14:00:00Z", "sentiment": { "label": "positive", "score": 0.727, "confidence": 0.73 } }, { "source": "news", "source_name": "Plos.org", "title": "GM-CSF orchestrates monocyte and granulocyte responses to Cryptococcus gattii", "description": "Author summary Cryptococcus gattii is an environmental fungus that can cause severe lung and brain infections after inhalation through the respiratory tract. C. gattii causes disease in patients with known immune deficits but also in individuals that are appa…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013418", "date": "2026-04-07", "published_at": "2026-04-07T14:00:00Z", "sentiment": { "label": "negative", "score": -0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "Plos.org", "title": "Genomic characterisation of Crimean-Congo haemorrhagic fever virus (CCHFV) in Tajikistan identifies a novel reassortant virus", "description": "Author summary Crimean-Congo haemorrhagic fever (CCHF) is a severe haemorrhagic disease caused by CCHF virus. The virus is found in Europe, Africa and Asia, and is predominantly transmitted by Hyalomma ticks. The negative-sense RNA genome is highly diverse an…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014204", "date": "2026-04-07", "published_at": "2026-04-07T14:00:00Z", "sentiment": { "label": "negative", "score": -0.077, "confidence": 0.08 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Elemental Analysis Market to Surpass USD 5.18 Billion by 2035, Driven by Rising Demand for Precise Material Characterization | SNS Insider", "description": "The Elemental Analysis Market is expanding as industries prioritize quality control and regulatory compliance, with the U.S. segment growing from USD 0.82 billion in 2025 to USD 1.45 billion by 2035. The Elemental Analysis Market is expanding as industries pr…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269302/0/en/Elemental-Analysis-Market-to-Surpass-USD-5-18-Billion-by-2035-Driven-by-Rising-Demand-for-Precise-Material-Characterization-SNS-Insider.html", "date": "2026-04-07", "published_at": "2026-04-07T13:30:00Z", "sentiment": { "label": "positive", "score": 0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Dermatomyositis Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status", "description": "The clinical trial report highlights opportunities in Dermatomyositis trials by revealing key trends in trial phases, sponsor types, and regions, particularly in G7 and E7 countries. It aids strategic decision-making by identifying prime trial locations and o…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269299/28124/en/Dermatomyositis-Global-Clinical-Trials-Market-Review-Report-2026-Region-Country-G7-E7-Trial-Status-Trial-Phase-Sponsor-Type-and-End-Point-Status.html", "date": "2026-04-07", "published_at": "2026-04-07T13:28:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Market Review 2026: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status", "description": "The report identifies key market opportunities by revealing trends in global HIV clinical trials, highlighting trial hot spots, analyzing trial phases and statuses, and showcasing prominent drugs. It aids strategic business planning and investment by illustra…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269296/28124/en/Human-Immunodeficiency-Virus-HIV-Infections-AIDS-Global-Clinical-Trials-Market-Review-2026-Region-Country-G7-E7-Trial-Status-Trial-Phase-Sponsor-Type-and-End-Point-Status.html", "date": "2026-04-07", "published_at": "2026-04-07T13:27:00Z", "sentiment": { "label": "positive", "score": 0.599, "confidence": 0.6 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Fume Hood Market Size to Reach USD 1,132 Million by 2035, Owing to Rising Laboratory Safety Regulations and Pharma Investments | Research by SNS Insider", "description": "The Fume Hood Market is growing steadily as demand increases for safe and energy-efficient lab ventilation, with the U.S. segment rising from USD 192.98 million in 2025 to USD 298.97 million by 2035. The Fume Hood Market is growing steadily as demand increase…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3268832/0/en/Fume-Hood-Market-Size-to-Reach-USD-1-132-Million-by-2035-Owing-to-Rising-Laboratory-Safety-Regulations-and-Pharma-Investments-Research-by-SNS-Insider.html", "date": "2026-04-07", "published_at": "2026-04-07T06:30:00Z", "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "BBC News", "title": "Rugby Union Weekly", "description": "Ashy, Ugo & Chris dissect the round of 16 and preview some blockbuster quarter-finals.", "url": "https://www.bbc.co.uk/sounds/play/p0nbx08d", "date": "2026-04-06", "published_at": "2026-04-06T18:34:00Z", "sentiment": { "label": "positive", "score": 0.599, "confidence": 0.6 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Validation, Calibration and Standardization in Life Sciences Market to Reach $3.9 Billion by 2030, Fueled by Regulatory Demands and Digital Transformation", "description": "Increasing regulatory requirements and the need for data accuracy are driving demand for validation, calibration, and standardization in life sciences....", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268627/0/en/Global-Validation-Calibration-and-Standardization-in-Life-Sciences-Market-to-Reach-3-9-Billion-by-2030-Fueled-by-Regulatory-Demands-and-Digital-Transformation.html", "date": "2026-04-06", "published_at": "2026-04-06T18:00:00Z", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "The Irish Times", "title": "Owen Doyle: Intrusive TMO involvement cost Ospreys a famous win against Ulster", "description": "Decision by referee Anthony Woodthorpe and his TMO David Roseon completely misread the situation and it was a blot on the Challenge Cup", "url": "https://www.irishtimes.com/sport/rugby/2026/04/06/owen-doyle-intrusive-tmo-involvement-cost-ospreys-a-famous-win-against-ulster/", "date": "2026-04-06", "published_at": "2026-04-06T16:46:05Z", "sentiment": { "label": "positive", "score": 0.403, "confidence": 0.4 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development", "description": "Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Mo…", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268553/0/en/Biodesix-Announces-AACR-2026-Posters-and-Presentations-Highlighting-Novel-Diagnostic-Test-Discovery-Pipeline-Development.html", "date": "2026-04-06", "published_at": "2026-04-06T15:43:00Z", "sentiment": { "label": "positive", "score": 0.71, "confidence": 0.71 } }, { "source": "pubmed", "pmid": "41998286", "title": "SLC33A1 exports oxidized glutathione to maintain endoplasmic reticulum redox homeostasis.", "authors": "Liu S et al.", "journal": "Nature cell biology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41998286/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41997165", "title": "Signe de cils in peripheral facial palsy.", "authors": "Oancea A et al.", "journal": "Lancet (London, England)", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41997165/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996931", "title": "Esophageal papillomas and human papillomavirus infection: A case series, scoping review and analysis.", "authors": "Egg M et al.", "journal": "Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996931/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996733", "title": "Preparation method for in situ tensile testing in transmission electron microscopy based on push-to-pull chip.", "authors": "Huang R et al.", "journal": "Ultramicroscopy", "date": "2026 Apr 5", "url": "https://pubmed.ncbi.nlm.nih.gov/41996733/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996200", "title": "Native Top-Down Mass Spectrometry Combined with High-Resolution Charge Variant Analysis of Trastuzumab Originator and Biosimilars.", "authors": "Beaumal C et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996200/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996158", "title": "Quantitative Host Cell Protein Analysis of Antibody-Based Protein Therapeutics Using the Orbitrap Astral Mass Spectrometer.", "authors": "Smith J et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996158/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41993889", "title": "Tackling Neutrophilic Inflammation in Bronchiectasis: From Macrolides to Cathepsin C Inhibitors.", "authors": "Gramegna A et al.", "journal": "Journal of inflammation research", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41993889/", "sentiment": { "label": "negative", "score": -0.25, "confidence": 0.25 } }, { "source": "pubmed", "pmid": "41991782", "title": "Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.", "authors": "Dias-Barbosa C et al.", "journal": "The patient", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41991782/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41989977", "title": "Clusters of Invasive Haemophilus influenzae Type b Disease Among Adults Using Substances or Experiencing Homelessness or Housing Instability - Alaska, Oregon, and Washington, 2023─2025.", "authors": "Collins JP et al.", "journal": "MMWR. Morbidity and mortality weekly report", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41989977/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41986708", "title": "Molecular basis for methylation-sensitive editing by Cas9.", "authors": "Roth MO et al.", "journal": "Nature", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41986708/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41984154", "title": "Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry.", "authors": "Yildirim M et al.", "journal": "Clinical research in cardiology : official journal of the German Cardiac Society", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41984154/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41979819", "title": "Sexual Dysfunction with Antipsychotics: Emerging Clues from a Disproportionality Analysis of the World Health Organization VigiBase.", "authors": "Pavlidis E et al.", "journal": "Drug safety", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41979819/", "sentiment": { "label": "negative", "score": -0.421, "confidence": 0.42 } }, { "source": "pubmed", "pmid": "41972211", "title": "Electroencephalography during acute painful procedures in neonates: a scoping review.", "authors": "Gunawan PY et al.", "journal": "Pain reports", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41972211/", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "pubmed", "pmid": "41969623", "title": "Diversity in clinical Trials: The example of systemic lupus erythematosus.", "authors": "Bevan A et al.", "journal": "Contemporary clinical trials communications", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41969623/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41967561", "title": "Pre-analytic error and possible misinterpretation for macrotroponin.", "authors": "Kavsak PA et al.", "journal": "Clinical biochemistry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41967561/", "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "41966763", "title": "IgE And IgG Antibody Responses to α-Gal and Association With Carotid Stenosis in Swedish Patients.", "authors": "Perusko M et al.", "journal": "Allergy", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41966763/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41965847", "title": "Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.", "authors": "Palmason R et al.", "journal": "Blood cancer journal", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41965847/", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41965748", "title": "Experimental and computational methods for allelic imbalance analysis from single-nucleus RNA-seq data.", "authors": "Simmons SK et al.", "journal": "Genome biology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41965748/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41963505", "title": "The role of the molecular tumor board: learnings from the ROME trial.", "authors": "Marchetti P et al.", "journal": "NPJ precision oncology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41963505/", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "pubmed", "pmid": "41962871", "title": "An adaptive quantification scheme for profiling serum antibody level in transplant immunology.", "authors": "Schacker T et al.", "journal": "Transplant immunology", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41962871/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41960723", "title": "Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study.", "authors": "Michaels-Igbokwe C et al.", "journal": "Leukemia & lymphoma", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41960723/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41960557", "title": "Clinical phenotypes and molecular endotypes of chronic urticaria: Linking clinical expression to underlying immune mechanisms.", "authors": "Türk M et al.", "journal": "Asia Pacific allergy", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41960557/", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "pubmed", "pmid": "41957135", "title": "Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.", "authors": "Ozawa Y et al.", "journal": "British journal of cancer", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41957135/", "sentiment": { "label": "negative", "score": -0.718, "confidence": 0.72 } }, { "source": "pubmed", "pmid": "41953806", "title": "Melatonin promotes stomatal immunity by mediating phytohormone crosstalk in Arabidopsis thaliana.", "authors": "Li Y et al.", "journal": "Frontiers in plant science", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41953806/", "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "pubmed", "pmid": "41951782", "title": "Reproductive hormone stability with prolonged intranasal oxytocin in adults with obesity.", "authors": "Galbiati F et al.", "journal": "International journal of obesity (2005)", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41951782/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41951141", "title": "Expanding the Global Map of Protein Post Translational Modifications with Immunoaffinity Enrichment and nDIA Analysis on the Orbitrap Astral Mass Spectrometer.", "authors": "Kumar M et al.", "journal": "Molecular & cellular proteomics : MCP", "date": "2026 Apr 6", "url": "https://pubmed.ncbi.nlm.nih.gov/41951141/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41950525", "title": "Toward Molecular Forensics of Agrochemicals with Orbitrap IRMS: Isotopic Fingerprints of Imidacloprid Sources and Elucidating Hydrolysis.", "authors": "Niemann F et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41950525/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41950519", "title": "Cross-Sectional Imaging of the WS(2) Nanotube Formation Pathways.", "authors": "Bukvisova K et al.", "journal": "Nano letters", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41950519/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41947768", "title": "First 20 Years of Orbitrap Mass Spectrometry as the Mainstream Analytical Technique.", "authors": "Makarov A", "journal": "Mass spectrometry reviews", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41947768/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41938080", "title": "Clinical Concordance of Pan Lung Cancer PCR Panel Covering 167 Actionable Variants Across 11 Genes and Other Validated Assays in the LC-SCRUM-Asia Registry.", "authors": "Matsumoto S et al.", "journal": "JTO clinical and research reports", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41938080/", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "pubmed", "pmid": "41937341", "title": "Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report.", "authors": "Mori F et al.", "journal": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41937341/", "sentiment": { "label": "negative", "score": -0.226, "confidence": 0.23 } }, { "source": "pubmed", "pmid": "41934444", "title": "Reply.", "authors": "Custovic D et al.", "journal": "The Journal of allergy and clinical immunology", "date": "2026 Apr 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41934444/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41933068", "title": "Longer duration of amenorrhea is associated with lower delay discounting and less hedonic eating in girls and young women with low-weight eating disorders.", "authors": "Wronski ML et al.", "journal": "Scientific reports", "date": "2026 Apr 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41933068/", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "pubmed", "pmid": "41929003", "title": "GlycoDiveR: a modular R framework to analyze and visualize highly dimensional glycoproteomics data.", "authors": "Veth TS et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41929003/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41928234", "title": "Transcriptomics analysis identifies folding and secretion related genes for improving monoclonal antibody production in Thermothelomyces heterothallica C1.", "authors": "Mäkinen M et al.", "journal": "Microbial cell factories", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41928234/", "sentiment": { "label": "positive", "score": 0.421, "confidence": 0.42 } }, { "source": "pubmed", "pmid": "41926944", "title": "[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].", "authors": "Klimek L et al.", "journal": "Laryngo- rhino- otologie", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41926944/", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41925420", "title": "Harnessing the lung microbiome for precision management of fibrotic lung disease.", "authors": "Leroy S et al.", "journal": "Trends in molecular medicine", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41925420/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41923638", "title": "Learning multi-cellular representations of single-cell transcriptomics data enables characterization of patient-level disease states.", "authors": "Liu T et al.", "journal": "Cell systems", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41923638/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41920124", "title": "Revisiting age- and sex-dependent serum tryptase reference intervals: Is additional evidence needed to refine current estimates?", "authors": "Chantran Y et al.", "journal": "The Journal of allergy and clinical immunology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41920124/", "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "pubmed", "pmid": "41919739", "title": "Implementing Annotation Confidence Scoring in Untargeted Mass Spectrometry Workflows for Small Molecule Analysis.", "authors": "Krakko D et al.", "journal": "Analytical chemistry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41919739/", "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "pubmed", "pmid": "41918709", "title": "Modelling lowering of raised blood pressure in pregnancy to reduce pre-eclampsia: secondary analysis of data from prospective cohort studies.", "authors": "Wright A et al.", "journal": "BMJ medicine", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41918709/", "sentiment": { "label": "negative", "score": -0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41917520", "title": "Associations Between Different Eosinophil Activity Markers and Clinical Outcomes in Young Asthmatics.", "authors": "Jõgi NO et al.", "journal": "Clinical and translational allergy", "date": "2026-04-18", "url": "https://pubmed.ncbi.nlm.nih.gov/41917520/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41915787", "title": "An increased number of heterozygous calls in the AxiomTM Equine Genotyping Array.", "authors": "Gmel AI et al.", "journal": "G3 (Bethesda, Md.)", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41915787/", "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "pubmed", "pmid": "41913717", "title": "Visualization of Multi-indication Randomized Control Trial Evidence to Support Decision Making in Oncology: A Case Study on Bevacizumab.", "authors": "Anwer S et al.", "journal": "Medical decision making : an international journal of the Society for Medical Decision Making", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41913717/", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "41912495", "title": "Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification.", "authors": "Andersen LS et al.", "journal": "Blood cancer journal", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41912495/", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41910757", "title": "[Olanzapine long acting injectable in new application form-Hope for the absence of post-injection delirium/sedation syndromes].", "authors": "Paulzen M et al.", "journal": "Der Nervenarzt", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41910757/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41910519", "title": "Reply.", "authors": "Gattinger P et al.", "journal": "The Journal of allergy and clinical immunology", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41910519/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41903301", "title": "Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).", "authors": "Kanemura H et al.", "journal": "European journal of cancer (Oxford, England : 1990)", "date": "2026 May 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41903301/", "sentiment": { "label": "positive", "score": 0.527, "confidence": 0.53 } }, { "source": "pubmed", "pmid": "41903103", "title": "Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Thailand: Epidemiological Data Update.", "authors": "Thakkar K et al.", "journal": "Pulmonary therapy", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41903103/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41896400", "title": "Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.", "authors": "Meeraus W et al.", "journal": "Infectious diseases and therapy", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41896400/", "sentiment": { "label": "negative", "score": -0.67, "confidence": 0.67 } } ] } }